BCKDHB

UniProt ID: P21953
Organism: Homo sapiens
Review Status: INITIALIZED
πŸ“ Provide Detailed Feedback

Gene Description

BCKDHB encodes the beta subunit (E1-beta / BCKDE1B) of the E1 component of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKDH) complex. Together with the E1-alpha subunit (BCKDHA) it forms an alpha2-beta2 heterotetrameric, thiamine diphosphate (ThDP)-dependent decarboxylase (2-oxoisovalerate dehydrogenase, EC 1.2.4.4). This E1 decarboxylase catalyses the first, committed and rate-limiting step of branched-chain amino acid (BCAA) catabolism: the oxidative decarboxylation of the branched-chain 2-oxo (alpha-keto) acids derived from valine, leucine and isoleucine (2-oxoisovalerate/KIV, 4-methyl-2-oxopentanoate/KIC, and (S)-3-methyl-2-oxopentanoate/KMV), producing CO2 and a branched-chain acyl group that is reductively transferred to the lipoyl cofactor of the E2 transacylase. The active site lies at the alpha-beta' interface, and the beta subunit contributes residues for ThDP binding, structural K+ coordination, and heterotetramer/E2 assembly. The full BCKDH multienzyme complex is organized around a 24-meric E2 (DBT) cubic core, to which multiple E1 (BCKDHA/BCKDHB) tetramers and E3 (DLD) dimers associate; complex activity is regulated by reversible phosphorylation of E1-alpha (by BCKDK) and dephosphorylation (by PPM1K/PP2Cm). BCKDHB acts in the mitochondrial matrix. Biallelic loss-of-function variants in BCKDHB cause maple syrup urine disease type Ib (MSUD 1B), in which loss of the beta subunit also destabilizes the alpha subunit and abolishes complex activity.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0009083 branched-chain amino acid catabolic process
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) propagation of the core biological process. As the E1-beta subunit of the BCKDH complex, BCKDHB is directly required for the committed, rate-limiting oxidative decarboxylation step of BCAA (valine/leucine/isoleucine) catabolism.
Reason: Correct and central to the gene's function; well supported by direct experimental evidence in human and orthologs. This is a core biological process for BCKDHB.
Supporting Evidence:
UniProtKB:P21953
Together with BCKDHA forms the heterotetrameric E1 subunit of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) complex. The BCKD complex catalyzes the multi-step oxidative decarboxylation of alpha-ketoacids derived from the branched-chain amino-acids valine, leucine and isoleucine producing CO2 and acyl-CoA
GO:0160157 branched-chain alpha-ketoacid dehydrogenase complex
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) assignment of the cellular component. BCKDHB is an integral, constitutive subunit of the BCKDH complex, forming (with BCKDHA) the E1 alpha2-beta2 decarboxylase that associates with the E2 (DBT) core and E3 (DLD).
Reason: Correct core localization to the multienzyme complex; supported by structural, biochemical and disease genetics evidence (heterotetrameric E1 component).
Supporting Evidence:
UniProtKB:P21953
Heterotetramer of 2 alpha/BCKDHA and 2 beta chains/BCKDHB that forms the branched-chain alpha-keto acid decarboxylase (E1) component of the BCKD complex
GO:0007584 response to nutrient
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Phylogenetic (IBA) annotation reflecting that BCAA catabolic flux through BCKDH is nutritionally regulated. This is a broad, downstream physiological process rather than the molecular role of the beta subunit.
Reason: Not wrong at the pathway level (BCKDH activity is modulated by nutrient status via BCKDK/PPM1K), but this is a peripheral, non-core physiological association for the E1-beta subunit, not its direct molecular function.
GO:0003863 branched-chain 2-oxo acid dehydrogenase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic (IEA) assignment of the E1 decarboxylase molecular function (EC 1.2.4.4), mapped via ortholog, RHEA reactions (RHEA:13457/84639/84643) and EC. This is the core catalytic activity of the BCKDH E1 component.
Reason: The mapping is correct and matches the UniProt catalytic activity and the experimental IDA/IMP annotations of the same term. The IEA uses 'enables' whereas the manual annotations use 'contributes_to'; contributes_to is technically more precise for a subunit of a shared active site, but the IEA is not wrong at this level and captures the correct enzymatic function.
Supporting Evidence:
UniProtKB:P21953
Reaction=N(6)-[(R)-lipoyl]-L-lysyl-[protein] + 3-methyl-2-oxobutanoate
file:human/BCKDHB/BCKDHB-deep-research-falcon.md
thiamine diphosphate (ThDP)-dependent decarboxylase
GO:0005759 mitochondrial matrix
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic (IEA) assignment of mitochondrial matrix localization via ortholog and UniProt subcellular location keyword. BCKDH is a soluble matrix multienzyme complex.
Reason: Correct and consistent with the UniProt subcellular location and with NAS/ISS/TAS annotations of the same term.
Supporting Evidence:
UniProtKB:P21953
SUBCELLULAR LOCATION: Mitochondrion matrix
GO:0005515 protein binding
IPI
PMID:12902323
Roles of His291-alpha and His146-beta' in the reductive acyl...
MARK AS OVER ANNOTATED
Summary: IPI 'protein binding' annotation whose WITH/FROM is UniProtKB:P12694 (BCKDHA), i.e. the direct E1-alpha partner with which BCKDHB forms the alpha2-beta2 heterotetramer. This paper dissects the catalytic mechanism (His-alpha/His-beta' in reductive acylation) of the assembled E1.
Reason: The interaction is real (BCKDHB obligately binds BCKDHA), but the bare 'protein binding' term is uninformative. The biologically meaningful capture of this interaction is already provided by the E1 heterotetramer / BCKDH complex annotations (GO:0160157) and the E1 decarboxylase molecular function (GO:0003863).
Supporting Evidence:
UniProtKB:P21953
P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;
GO:0005515 protein binding
IPI
PMID:15166214
Cross-talk between thiamin diphosphate binding and phosphory...
MARK AS OVER ANNOTATED
Summary: IPI 'protein binding' annotation, WITH/FROM UniProtKB:P12694 (BCKDHA). This study addresses ThDP-binding / phosphorylation-loop cross-talk in the assembled E1 decarboxylase, again reflecting the BCKDHB-BCKDHA E1 heterotetramer.
Reason: Real interaction but uninformative bare 'protein binding'. The E1 heterotetramer is better captured by the BCKDH complex (GO:0160157) and E1 activity (GO:0003863) annotations.
Supporting Evidence:
UniProtKB:P21953
P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;
GO:0005515 protein binding
IPI
PMID:15576032
Molecular mechanism for regulation of the human mitochondria...
MARK AS OVER ANNOTATED
Summary: IPI 'protein binding' annotation, WITH/FROM UniProtKB:P12694 (BCKDHA). This paper concerns regulation of the assembled BCKDH complex by phosphorylation of E1-alpha, again reflecting the E1 heterotetramer interaction.
Reason: Real interaction but uninformative bare 'protein binding'; the meaningful content is captured by the complex (GO:0160157) and MF (GO:0003863) annotations.
Supporting Evidence:
UniProtKB:P21953
P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
MARK AS OVER ANNOTATED
Summary: Large-scale interactome (BioPlex) IPI, WITH/FROM UniProtKB:P12694 (BCKDHA), recovering the BCKDHB-BCKDHA interaction that constitutes the E1 heterotetramer.
Reason: High-throughput detection of the genuine E1-alpha/E1-beta interaction, but the generic 'protein binding' term is uninformative and the interaction is already captured by the BCKDH complex annotation (GO:0160157).
Supporting Evidence:
UniProtKB:P21953
P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
MARK AS OVER ANNOTATED
Summary: Large-scale interactome (BioPlex 3.0) IPI, WITH/FROM UniProtKB:P12694 (BCKDHA), again capturing the BCKDHB-BCKDHA E1 heterotetramer interaction.
Reason: Genuine but uninformative bare 'protein binding'; the meaningful E1-alpha interaction is captured by the BCKDH complex (GO:0160157) and E1 MF (GO:0003863).
Supporting Evidence:
UniProtKB:P21953
P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;
GO:0006550 L-isoleucine catabolic process
IEA
GO_REF:0000107
ACCEPT
Summary: Electronic (Ensembl Compara ortholog) transfer of a more granular BCAA subprocess. The BCKDH E1 decarboxylates KMV (the isoleucine-derived 2-oxo acid), so this is a correct, more specific descendant of BCAA catabolism.
Reason: Biochemically correct - the E1 decarboxylase acts on the isoleucine-derived branched-chain 2-oxo acid (S)-3-methyl-2-oxopentanoate (KMV). More granular than, and consistent with, the core GO:0009083 annotation; retain as non-core detail.
Supporting Evidence:
UniProtKB:P21953
Reaction=N(6)-[(R)-lipoyl]-L-lysyl-[protein] + (S)-3-methyl-2-
PMID:3593587
The BCKADH effectively oxidized all of KIV, KIC, and KMV
GO:0006552 L-leucine catabolic process
IEA
GO_REF:0000107
ACCEPT
Summary: Electronic (Ensembl Compara ortholog) transfer. The BCKDH E1 decarboxylates KIC (4-methyl-2-oxopentanoate), the leucine-derived 2-oxo acid, so this granular BCAA subprocess is correct.
Reason: Biochemically correct (E1 acts on the leucine-derived branched-chain 2-oxo acid, 4-methyl-2-oxopentanoate/KIC). More specific than, and consistent with, the core GO:0009083 annotation; retain as non-core detail.
Supporting Evidence:
UniProtKB:P21953
Reaction=N(6)-[(R)-lipoyl]-L-lysyl-[protein] + 4-methyl-2-oxopentanoate
PMID:3593587
The BCKADH effectively oxidized all of KIV, KIC, and KMV
GO:0006574 L-valine catabolic process
IEA
GO_REF:0000107
ACCEPT
Summary: Electronic (Ensembl Compara ortholog) transfer. The BCKDH E1 decarboxylates KIV (3-methyl-2-oxobutanoate), the valine-derived 2-oxo acid, so this granular BCAA subprocess is correct.
Reason: Biochemically correct (E1 acts on the valine-derived branched-chain 2-oxo acid, 3-methyl-2-oxobutanoate/KIV; RHEA:13457 is the experimentally verified human reaction). More specific than, and consistent with, the core GO:0009083 annotation; retain as non-core detail.
Supporting Evidence:
UniProtKB:P21953
Reaction=N(6)-[(R)-lipoyl]-L-lysyl-[protein] + 3-methyl-2-oxobutanoate
PMID:3593587
The BCKADH effectively oxidized all of KIV, KIC, and KMV
GO:0032991 protein-containing complex
IEA
GO_REF:0000107
MODIFY
Summary: Electronic (Ensembl Compara ortholog) transfer of the generic 'protein-containing complex' term. BCKDHB is a subunit of the specific, well-defined BCKDH complex.
Reason: Correct but far too general: BCKDHB is part of the specific branched-chain alpha-ketoacid dehydrogenase complex, which is already directly annotated (GO:0160157) with stronger evidence. Replace the generic term with the specific one.
Supporting Evidence:
UniProtKB:P21953
Heterotetramer of 2 alpha/BCKDHA and 2 beta chains/BCKDHB that forms the branched-chain alpha-keto acid decarboxylase (E1) component of the BCKD complex
GO:0005759 mitochondrial matrix
NAS
PMID:3593587
Purification and characterization of human liver branched-ch...
ACCEPT
Summary: Non-traceable author statement (ComplexPortal-assigned) of matrix localization, supported by purification of the intact human liver BCKDH complex, a soluble matrix multienzyme complex.
Reason: Consistent with all other matrix annotations and with UniProt subcellular location. Correct core localization.
Supporting Evidence:
PMID:3593587
Purification and characterization of human liver branched-chain alpha-keto acid dehydrogenase complex.
GO:0009083 branched-chain amino acid catabolic process
IDA
PMID:3593587
Purification and characterization of human liver branched-ch...
ACCEPT
Summary: Direct experimental (IDA) annotation of the core BCAA catabolic process. The purified human liver BCKDH complex oxidized all three branched-chain 2-oxo acids (KIV, KIC, KMV), demonstrating its role in BCAA (valine/leucine/isoleucine) catabolism.
Reason: Direct biochemical evidence for the complex's role in BCAA catabolism; this is a core process for BCKDHB.
Supporting Evidence:
PMID:3593587
The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding apparent Km values in the range of 14-17 microM for those alpha-keto acids.
GO:0160157 branched-chain alpha-ketoacid dehydrogenase complex
IPI
PMID:3593587
Purification and characterization of human liver branched-ch...
ACCEPT
Summary: ComplexPortal (CPX-2216) IPI annotation of BCKDHB as a subunit of the BCKDH complex, based on co-purification of the intact human liver complex.
Reason: Correct core complex membership, supported by biochemical purification showing the subunit composition of the human liver BCKDH complex.
Supporting Evidence:
PMID:3593587
the purified enzyme complex gave three major bands having molecular weights of 51,000, 46,000, and 36,000
GO:0005739 mitochondrion
IDA
GO_REF:0000052
ACCEPT
Summary: Human Protein Atlas immunofluorescence (IDA) localization of BCKDHB to mitochondria. Less granular than the matrix annotations but consistent.
Reason: Correct localization; mitochondrion is a valid parent of the more specific mitochondrial matrix localization also annotated. Directly supported by immunofluorescence.
GO:0005759 mitochondrial matrix
NAS
PMID:10745006
Crystal structure of human branched-chain alpha-ketoacid deh...
ACCEPT
Summary: Author statement (NAS, UniProt) of mitochondrial matrix localization, associated with the crystal structure paper of the human E1b heterotetramer.
Reason: Consistent with the UniProt subcellular location and all other matrix annotations; correct core localization.
Supporting Evidence:
UniProtKB:P21953
SUBCELLULAR LOCATION: Mitochondrion matrix
GO:0005759 mitochondrial matrix
ISS
GO_REF:0000024
ACCEPT
Summary: Sequence-similarity (ISS) transfer from ortholog (UniProtKB:P21839, rat E1-beta) asserting BCKDHB is active in the mitochondrial matrix, where the BCKDH complex functions.
Reason: Correct: the E1 decarboxylase acts within the mitochondrial matrix as part of the BCKDH complex. The 'is_active_in' qualifier appropriately links localization to the site of catalytic function.
Supporting Evidence:
UniProtKB:P21953
SUBCELLULAR LOCATION: Mitochondrion matrix
GO:0120552 branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA
IMP
PMID:10745006
Crystal structure of human branched-chain alpha-ketoacid deh...
ACCEPT
Summary: Mutant-phenotype (IMP) annotation to the specific process of branched-chain alpha-keto acid decarboxylation. The crystal structure of human E1b rationalizes how MSUD mutations in the beta subunit impair this decarboxylation step.
Reason: Accurate, appropriately specific description of the E1 decarboxylase step in which BCKDHB participates. Supported by structural/mutational analysis of MSUD variants.
Supporting Evidence:
PMID:10745006
The known MSUD mutations affect the functioning of E1b by interfering with the cofactor and K(+) sites, the packing of hydrophobic cores, and the precise arrangement of residues at or near several subunit interfaces.
GO:0120552 branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA
IDA
PMID:3593587
Purification and characterization of human liver branched-ch...
ACCEPT
Summary: Direct experimental (IDA) annotation to the branched-chain alpha-keto acid decarboxylation process, supported by the purified human liver BCKDH complex oxidizing all three branched-chain 2-oxo acids.
Reason: Correct, appropriately specific process describing the reaction the E1 component (including BCKDHB) initiates. Directly supported by biochemical characterization.
Supporting Evidence:
PMID:3593587
The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding apparent Km values in the range of 14-17 microM for those alpha-keto acids.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-9865121
ACCEPT
Summary: Reactome (TAS) matrix localization annotation from a curated pathway reaction involving the BCKDH complex.
Reason: Consistent with the UniProt subcellular location and the other matrix annotations; correct core localization from a curated pathway source.
GO:0005739 mitochondrion
HTP
PMID:34800366
Quantitative high-confidence human mitochondrial proteome an...
ACCEPT
Summary: High-throughput (HTP) mitochondrial proteomics localization of BCKDHB to mitochondria (Morgenstern et al. high-confidence human mitochondrial proteome).
Reason: Consistent with all other localization evidence; a valid (if less specific) parent of the mitochondrial matrix localization. Correct.
Supporting Evidence:
PMID:34800366
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.
GO:0160157 branched-chain alpha-ketoacid dehydrogenase complex
IMP
PMID:2022752
Maple syrup urine disease. Complete defect of the E1 beta su...
ACCEPT
Summary: Mutant-phenotype (IMP) evidence that BCKDHB is part of the BCKDH complex: an 11-bp deletion abolishing the beta subunit destabilizes E1-alpha and reduces complex activity to ~6% of normal, demonstrating BCKDHB is a required structural subunit.
Reason: Strong genetic/biochemical evidence that BCKDHB is an integral subunit of the BCKDH complex whose absence disassembles/inactivates the enzyme. Core complex membership.
Supporting Evidence:
PMID:2022752
The absence of the E1 beta subunit results in instability of the E1 alpha subunit.
GO:0160157 branched-chain alpha-ketoacid dehydrogenase complex
IDA
PMID:9582350
Impaired assembly of E1 decarboxylase of the branched-chain ...
ACCEPT
Summary: Direct experimental (IDA) evidence that BCKDHB is a subunit of the E1 component: reconstitution/assembly studies show wild-type E1 exists as alpha2-beta2 tetramers of E1-alpha and E1-beta.
Reason: Directly demonstrates BCKDHB as part of the E1 decarboxylase of the BCKDH complex (alpha2-beta2 tetramer). Core complex membership.
Supporting Evidence:
PMID:9582350
The E1 decarboxylase component of the human branched-chain ketoacid dehydrogenase complex comprises two E1alpha (45.5 kDa) and two E1beta (37.5 kDa) subunits forming an alpha2 beta2 tetramer.
GO:0160157 branched-chain alpha-ketoacid dehydrogenase complex
IDA
PMID:10745006
Crystal structure of human branched-chain alpha-ketoacid deh...
ACCEPT
Summary: Direct experimental (IDA) evidence from the crystal structure of the human E1b component (170 kDa alpha2-beta2 heterotetramer), establishing BCKDHB as an integral subunit of the BCKDH complex.
Reason: Structural determination of the E1b heterotetramer directly demonstrates BCKDHB as part of the complex. Core complex membership.
Supporting Evidence:
PMID:10745006
the 170 kDa alpha(2)beta(2) heterotetrameric E1b component of the branched-chain alpha-ketoacid dehydrogenase multienzyme complex.
GO:0003863 branched-chain 2-oxo acid dehydrogenase activity
IDA
PMID:10745006
Crystal structure of human branched-chain alpha-ketoacid deh...
ACCEPT
Summary: Direct experimental (IDA) annotation with the appropriate 'contributes_to' qualifier: BCKDHB contributes to the E1 decarboxylase molecular function. The crystal structure shows the active site at the alpha-beta' interface, with beta subunit residues involved in cofactor and K+ binding.
Reason: Core molecular function. 'contributes_to' correctly reflects that catalysis requires both subunits (active site at alpha-beta' interface); BCKDHB alone does not carry the full activity but is essential to it.
Supporting Evidence:
PMID:10745006
The position of two important potassium (K(+)) ions was determined.
UniProtKB:P21953
The E1 subunit catalyzes the first step with the decarboxylation of the alpha-ketoacid
GO:0003863 branched-chain 2-oxo acid dehydrogenase activity
IDA
PMID:9582350
Impaired assembly of E1 decarboxylase of the branched-chain ...
ACCEPT
Summary: Direct experimental (IDA) annotation of the E1 decarboxylase activity with 'contributes_to'. E1-alpha missense mutations abolish E1 and BCKDH catalytic activity, and BCKDHB is a required subunit of the catalytically competent alpha2-beta2 E1.
Reason: Core molecular function; 'contributes_to' is correct for a shared active site formed by the alpha2-beta2 heterotetramer.
Supporting Evidence:
PMID:9582350
the E1alpha subunit is affected, resulting in the loss of E1 and branched-chain ketoacid dehydrogenase catalytic activities.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-5693148
ACCEPT
Summary: Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction involving the BCKDH complex.
Reason: Consistent with all other matrix localization evidence; correct core localization.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-5693153
ACCEPT
Summary: Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction involving the BCKDH complex.
Reason: Consistent with all other matrix localization evidence; correct core localization.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-9912527
ACCEPT
Summary: Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction (BCKDH dephosphorylation by PPM1K) involving the BCKDH complex.
Reason: Consistent with all other matrix localization evidence; correct core localization.
GO:0003863 branched-chain 2-oxo acid dehydrogenase activity
IMP
PMID:2022752
Maple syrup urine disease. Complete defect of the E1 beta su...
ACCEPT
Summary: Mutant-phenotype (IMP) evidence for the E1 decarboxylase activity: loss of the beta subunit reduces BCKDH activity to ~6% of normal, demonstrating BCKDHB is required for the complex's dehydrogenase activity. Annotated with 'contributes_to'.
Reason: Core molecular function supported by loss-of-function genetics; 'contributes_to' is appropriate for a subunit of the shared active site.
Supporting Evidence:
PMID:2022752
The BCKDH activity in the proband with MSUD was approximately 6% of the normal control level.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-9859148
ACCEPT
Summary: Reactome (TAS) mitochondrial matrix localization from the curated reaction in which the BCKDHA:BCKDHB E1 tetramer decarboxylates KIC, KMV and KIV.
Reason: Consistent with all other matrix localization evidence and directly describes the E1 catalytic reaction. Correct core localization.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-9859163
ACCEPT
Summary: Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction involving the BCKDH complex.
Reason: Consistent with all other matrix localization evidence; correct core localization.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-9859172
ACCEPT
Summary: Reactome (TAS) mitochondrial matrix localization from the curated reaction in which the DLD (E3) dimer dehydrogenates dihydrolipoyl, part of the BCKDH complex cycle.
Reason: Consistent with all other matrix localization evidence; correct core localization.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-9865115
ACCEPT
Summary: Reactome (TAS) mitochondrial matrix localization from a curated reaction involving DBT (E2) loss-of-function within the BCKDH pathway.
Reason: Consistent with all other matrix localization evidence; correct core localization.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-9907572
ACCEPT
Summary: Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction involving the BCKDH complex.
Reason: Consistent with all other matrix localization evidence; correct core localization.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-9912480
ACCEPT
Summary: Reactome (TAS) mitochondrial matrix localization from the curated reaction in which BCKDK loss-of-function mutations fail to phosphorylate BCKDH.
Reason: Consistent with all other matrix localization evidence; correct core localization.
GO:0005739 mitochondrion
IMP
PMID:2022752
Maple syrup urine disease. Complete defect of the E1 beta su...
ACCEPT
Summary: Mutant-phenotype (IMP) mitochondrial localization inference. The disease allele deletes part of the E1-beta mitochondrial targeting leader peptide, consistent with normal mitochondrial localization of the wild-type protein.
Reason: Correct localization; a valid parent of the mitochondrial matrix annotations. The mutation disrupts the mitochondrial targeting peptide, underscoring the protein's mitochondrial destination.
Supporting Evidence:
PMID:2022752
An 11-bp deletion was identified in the region that encoded the mitochondrial targeting leader peptide in the E1 beta cDNA.
GO:0009083 branched-chain amino acid catabolic process
IMP
PMID:2022752
Maple syrup urine disease. Complete defect of the E1 beta su...
ACCEPT
Summary: Mutant-phenotype (IMP) evidence for the core BCAA catabolic process: complete loss of the beta subunit causes MSUD (BCAA/BCKA accumulation) and reduces BCKDH activity to ~6% of normal, demonstrating BCKDHB's requirement for BCAA catabolism.
Reason: Strong loss-of-function evidence for a core biological process; MSUD 1B is the pathological consequence of impaired BCAA catabolism due to E1-beta deficiency.
Supporting Evidence:
PMID:2022752
These observations show the biological importance of the E1 beta subunit of BCKDH to maintain normal function of the enzyme activity.

Core Functions

E1-beta subunit of the BCKDH E1 decarboxylase; contributes (with BCKDHA) to the thiamine diphosphate-dependent oxidative decarboxylation of branched-chain 2-oxo (alpha-keto) acids, the committed and rate-limiting step of branched-chain amino acid catabolism.

Supporting Evidence:
  • UniProtKB:P21953
    Together with BCKDHA forms the heterotetrameric E1 subunit of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) complex.
  • PMID:10745006
    the 170 kDa alpha(2)beta(2) heterotetrameric E1b component of the branched-chain alpha-ketoacid dehydrogenase multienzyme complex.

References

file:human/BCKDHB/BCKDHB-deep-research-falcon.md
BCKDHB (P21953) deep research report (falcon / Edison Scientific Literature)
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on curation of immunofluorescence data
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Combined Automated Annotation using Multiple IEA Methods
Crystal structure of human branched-chain alpha-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease.
Roles of His291-alpha and His146-beta' in the reductive acylation reaction catalyzed by human branched-chain alpha-ketoacid dehydrogenase: refined phosphorylation loop structure in the active site.
Cross-talk between thiamin diphosphate binding and phosphorylation loop conformation in human branched-chain alpha-keto acid decarboxylase/dehydrogenase.
Molecular mechanism for regulation of the human mitochondrial branched-chain alpha-ketoacid dehydrogenase complex by phosphorylation.
Maple syrup urine disease. Complete defect of the E1 beta subunit of the branched chain alpha-ketoacid dehydrogenase complex due to a deletion of an 11-bp repeat sequence which encodes a mitochondrial targeting leader peptide in a family with the disease.
Architecture of the human interactome defines protein communities and disease networks.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.
Purification and characterization of human liver branched-chain alpha-keto acid dehydrogenase complex.
Impaired assembly of E1 decarboxylase of the branched-chain alpha-ketoacid dehydrogenase complex in type IA maple syrup urine disease.
Reactome:R-HSA-5693148
BCKDK phosphorylates BCKDH
Reactome:R-HSA-5693153
PPM1K dephosphorylates p-BCKDH
Reactome:R-HSA-9859148
BCKDHA:BCKDHB tetramer decarboxylates KIC, KMVA, KIV
Reactome:R-HSA-9859163
DBT transfers BCAA to CoA
Reactome:R-HSA-9859172
DLD dimer dehydrogenates dihydrolipoyl
Reactome:R-HSA-9865115
DBT loss-of-function mutants don't synthesize BCAA-CoA
Reactome:R-HSA-9865121
BCKDHA or BCKDHB loss-of-function mutants don't synthesize BCAA-CoA
Reactome:R-HSA-9907572
Loss-of-function DLD mutants don't dehydrogenate dihydrolipoyl DBT
Reactome:R-HSA-9912480
BCKDK loss-of-function mutations do not phosphorylate BCKDH
Reactome:R-HSA-9912527
H139Hfs13* PPM1K does not dephosphorylate BCKDH

Deep Research

Falcon

(BCKDHB-deep-research-falcon.md)
Comprehensive Functional Annotation of BCKDHB (Human, UniProt: P21953) Falcon Edison Scientific Literature 36 citations 2 artifacts 2026-07-05T19:48:53.066645

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive Functional Annotation of BCKDHB (Human, UniProt: P21953)

1. Gene and Protein Identity

BCKDHB (branched-chain keto acid dehydrogenase E1 subunit beta) encodes the beta subunit of the E1 component of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKDH) complex. The protein is also designated 2-oxoisovalerate dehydrogenase subunit beta (EC 1.2.4.4). The gene maps to chromosome 6 in humans and its product is synthesized as a precursor with a mitochondrial targeting sequence that is cleaved upon import (Γ¦varsson2000crystalstructureof pages 1-2, billington2022genomicandbiochemical pages 1-3). The mature beta subunit comprises 342 residues with a molecular mass of approximately 37.8 kDa (Γ¦varsson2000crystalstructureof pages 1-2).

The following table summarizes the key molecular properties of BCKDHB:

Gene name UniProt ID Protein name Organism EC number Molecular weight Structure Cofactors Substrates Products Subcellular localization Key domains Disease association Regulatory mechanism
BCKDHB P21953 Branched-chain alpha-keto acid dehydrogenase E1 component beta chain; 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial Homo sapiens EC 1.2.4.4 E1Ξ² subunit ~37.8 kDa; E1 complex contains two 37.8 kDa Ξ² subunits plus two 45.5 kDa Ξ± subunits (Γ¦varsson2000crystalstructureof pages 1-2) Ξ±2Ξ²2 heterotetramer within the E1 component of the BCKDH complex; active sites formed at α–β′ interfaces (Γ¦varsson2000crystalstructureof pages 1-2, Γ¦varsson2000crystalstructureof pages 7-8, Γ¦varsson2000crystalstructureof pages 2-4) ThDP/TPP; K+ stabilizing site in Ξ² subunit (Γ¦varsson2000crystalstructureof pages 1-2, Γ¦varsson2000crystalstructureof pages 2-4, Γ¦varsson2000crystalstructureof pages 4-5) Branched-chain Ξ±-ketoacids: KIC (2-oxoisocaproate, from leucine), KMV (2-oxo-3-methylvalerate, from isoleucine), KIV (2-oxoisovalerate, from valine) (billington2022genomicandbiochemical pages 1-3, du2022theroleof pages 1-2) Corresponding branched-chain acyl-CoAs after oxidative decarboxylation: isovaleryl-CoA, Ξ±-methylbutyryl-CoA, isobutyryl-CoA + CO2 (via transfer to lipoyl-E2 during the BCKDH reaction) (billington2022genomicandbiochemical pages 1-3, du2022theroleof pages 1-2) Primarily mitochondrial matrix as part of the BCKDH complex; recent cardiac evidence also supports an extramitochondrial/ER-associated pool (du2022theroleof pages 2-4, ogawa2023downregulationofextramitochondrial pages 11-13, ogawa2023downregulationofextramitochondrial pages 9-11, weiss2024mitolnccontrolscardiac pages 10-12) THDP-binding and transketolase-like domains; Ξ² subunit contributes residues required for cofactor binding, metal coordination, and E2 interaction (Γ¦varsson2000crystalstructureof pages 2-4, Γ¦varsson2000crystalstructureof pages 10-12) Maple syrup urine disease (MSUD) type 1B caused by pathogenic BCKDHB variants; major disease gene in multiple population studies (margutti2020maplesyrupurine pages 2-4, campanholi2021molecularbasisof pages 1-2, rodriguezpombo2006mutationalspectrumof pages 1-3, OpenTargets Search: -BCKDHB) BCKDH complex is inhibited by BCKDK-mediated phosphorylation of the E1Ξ± subunit and activated by PPM1K/PP2Cm-mediated dephosphorylation; BCKAs such as KIC allosterically suppress BCKDK (huang2025branchedchainaminoacids pages 13-14, du2022theroleof pages 2-4, du2022theroleof pages 6-7)

Table: This table summarizes core molecular, biochemical, structural, localization, and disease-related properties of human BCKDHB. It is useful as a compact reference for functional annotation of the BCKDHB gene product within the BCKDH complex.

2. Enzymatic Function and Reaction Catalyzed

BCKDHB functions exclusively as part of the BCKDH multienzyme complex, which catalyzes the irreversible oxidative decarboxylation of the three branched-chain alpha-ketoacids (BCKAs) derived from the essential branched-chain amino acids (BCAAs) leucine, isoleucine, and valine. This represents the rate-limiting and committed step in the BCAA catabolic pathway (mei2026branchedchainaminoacids pages 3-5, huang2025branchedchainaminoacids pages 4-5).

The E1 component, composed of BCKDHA (alpha subunit) and BCKDHB (beta subunit) as an Ξ±β‚‚Ξ²β‚‚ heterotetramer, is a thiamine diphosphate (ThDP)-dependent decarboxylase (du2022theroleof pages 1-2, Γ¦varsson2000crystalstructureof pages 1-2). The three substrates and their products are:

  • Ξ±-Ketoisocaproate (KIC), derived from leucine β†’ isovaleryl-CoA
  • Ξ±-Keto-Ξ²-methylvalerate (KMV), derived from isoleucine β†’ Ξ±-methylbutyryl-CoA
  • Ξ±-Ketoisovalerate (KIV), derived from valine β†’ isobutyryl-CoA

In the reaction mechanism, the alpha-keto acid first binds to ThDP and is decarboxylated by E1. The resulting branched-chain acyl group is then oxidatively transferred to the lipoyl domain of the E2 (dihydrolipoamide branched-chain transacylase, encoded by DBT) subunit, which subsequently catalyzes transacylation to coenzyme A. E3 (dihydrolipoamide dehydrogenase, encoded by DLD) reoxidizes the reduced lipoyl groups and regenerates NAD⁺ (billington2022genomicandbiochemical pages 1-3, du2022theroleof pages 1-2). The resulting branched-chain acyl-CoAs are subsequently metabolized through pathways analogous to fatty acid β-oxidation, ultimately producing acetyl-CoA and succinyl-CoA for entry into the TCA cycle (mei2026branchedchainaminoacids pages 3-5, du2022theroleof pages 2-4).

The complete composition of the BCKDH complex is summarized below:

Component Gene(s) Subunit structure Function in the complex Key features
E1 BCKDHA, BCKDHB Ξ±2Ξ²2 heterotetramer ThDP-dependent oxidative decarboxylation of branched-chain Ξ±-ketoacids (KIC, KMV, KIV); initiates transfer of the acyl group to the lipoyl domain of E2 Active sites lie at α–β′ interfaces; human structure solved at 2.7 Γ…; Ξ² subunit contributes to ThDP binding, K+ coordination, and E2 interaction (billington2022genomicandbiochemical pages 1-3, Γ¦varsson2000crystalstructureof pages 1-2, Γ¦varsson2000crystalstructureof pages 7-8, Γ¦varsson2000crystalstructureof pages 2-4, Γ¦varsson2000crystalstructureof pages 4-5)
E2 DBT 24-mer core (branched-chain dihydrolipoamide acyltransferase scaffold) Accepts the branched-chain acyl group from E1 via its lipoyl domain and catalyzes transacylation to CoA, forming branched-chain acyl-CoAs Central architectural scaffold of the BCKDH complex; lipoyl domain shuttles reaction intermediates between active sites (billington2022genomicandbiochemical pages 1-3, he2026bcaasandrelated pages 8-10)
E3 DLD Homodimeric dihydrolipoamide dehydrogenase shared among multiple 2-oxoacid dehydrogenase complexes Reoxidizes reduced lipoyl groups on E2 and transfers electrons to NAD+, generating NADH Shared with PDH and OGDH complexes; common E3 module in mitochondrial 2-oxoacid dehydrogenase systems (billington2022genomicandbiochemical pages 1-3, he2026bcaasandrelated pages 8-10)
BCKDK BCKDK Regulatory kinase associated with the BCKDH complex Phosphorylates E1Ξ± to inhibit BCKDH activity Major negative regulator of BCAA oxidation; inhibited allosterically by BCKAs such as KIC; pharmacologic inhibition activates BCKDH (du2022theroleof pages 2-4, du2022theroleof pages 6-7, huang2025branchedchainaminoacids pages 2-4)
PPM1K PPM1K Mitochondrial PP2C-family phosphatase Dephosphorylates E1Ξ± to reactivate BCKDH Also called PP2Cm; opposes BCKDK to maintain BCAA/BCKA homeostasis and BCKDH flux (huang2025branchedchainaminoacids pages 13-14, du2022theroleof pages 2-4, du2022theroleof pages 6-7, huang2025branchedchainaminoacids pages 2-4)

Table: This table summarizes the catalytic and regulatory composition of the human BCKDH system, highlighting where BCKDHB fits within the E1 decarboxylase module. It is useful for functional annotation because it distinguishes the core enzyme subunits from the kinase/phosphatase regulators that control pathway activity.

3. Protein Structure and Role of the Beta Subunit

The crystal structure of human BCKDH E1 was determined at 2.7 Γ… resolution, revealing a tightly packed Ξ±β‚‚Ξ²β‚‚ heterotetramer (Γ¦varsson2000crystalstructureof pages 1-2). The beta subunit is organized into two similarly sized N-terminal and C-terminal domains, each with an Ξ±/Ξ² architecture containing a central Ξ²-sheet flanked by helices (Γ¦varsson2000crystalstructureof pages 2-4). The tetramer forms four distinct subunit interfaces: α–α′ (burying 3,215 Γ…Β²), α–β (1,993 Γ…Β²), α–β′ (1,890 Γ…Β²), and β–β′ (2,239 Γ…Β²). Remarkably, 46% of the beta subunit's accessible surface area is devoted to subunit interactions, underscoring its critical structural role in maintaining the tetrameric assembly (Γ¦varsson2000crystalstructureof pages 5-7).

The beta subunit makes several specific contributions to enzyme function:

  • ThDP cofactor binding: The active site is located at the α–β′ interface. Key beta subunit residues include Tyr102-Ξ²β€², which packs against the aminopyrimidine ring of ThDP; Leu74-Ξ²β€², which provides hydrophobic interactions; and Glu76-Ξ²β€², which directly coordinates the N1β€² atom of the cofactor (Γ¦varsson2000crystalstructureof pages 2-4).

  • Potassium ion coordination: A K⁺ binding site is located in the beta subunit at the interface with the C-terminal domain of the alpha subunit. This site is coordinated by residues Gly128-Ξ², Leu130-Ξ², Cys178-Ξ², Asp181-Ξ², and Asn183-Ξ², and is critical for structural stability (Γ¦varsson2000crystalstructureof pages 5-7, Γ¦varsson2000crystalstructureof pages 4-5).

  • Subunit–subunit interactions: His156-Ξ² is critical for β–β′ association through hydrophobic packing and hydrogen bonding with the neighboring beta subunit. Asn126-Ξ² forms a hydrogen bond network stabilizing local polypeptide conformation (Γ¦varsson2000crystalstructureof pages 7-8).

  • E2 binding: The beta subunits carry the binding site for the E2 binding domain at or near the twofold axis of the E1 tetramer, enabling assembly of the full multienzyme complex (Γ¦varsson2000crystalstructureof pages 10-12).

The extensive hydrophobic patches at subunit interfaces suggest that E1 assembly requires chaperonin (GroEL/GroES or its mitochondrial equivalent) assistance in vivo (Γ¦varsson2000crystalstructureof pages 5-7).

4. Subcellular Localization

BCKDHB is synthesized as a precursor protein in the cytoplasm with an N-terminal mitochondrial targeting sequence. Following import into mitochondria and cleavage of the signal peptide, the mature protein assembles into the BCKDH complex within the mitochondrial matrix (weiss2024mitolnccontrolscardiac pages 10-12, du2022theroleof pages 2-4). Subcellular fractionation and MitoTracker co-localization studies confirm the primarily mitochondrial localization of the BCKDH complex (weiss2024mitolnccontrolscardiac pages 10-12).

However, recent work has revealed that BCKDH can also localize to extramitochondrial compartments. In cardiac tissue, proteomic analyses combined with immunoblotting demonstrated that BCKDH localizes not only to mitochondria but also to the endoplasmic reticulum (ER), where it interacts with AMP deaminase 3 (AMPD3) (ogawa2023downregulationofextramitochondrial pages 11-13, ogawa2023downregulationofextramitochondrial pages 9-11). This finding is consistent with observations that related enzymes sharing the E3 subunit with BCKDH (pyruvate dehydrogenase and Ξ±-ketoglutarate dehydrogenase) also function in extramitochondrial compartments including the nucleus (ogawa2023downregulationofextramitochondrial pages 9-11). The functional significance of extramitochondrial BCKDH remains an active area of investigation.

5. Biochemical Pathway Context

The BCAA catabolic pathway is initiated by the reversible transamination of BCAAs to their corresponding BCKAs by branched-chain aminotransferases (BCAT1, cytosolic; BCAT2, mitochondrial) (huang2025branchedchainaminoacids pages 4-5, mei2026branchedchainaminoacids pages 3-5). BCAAs are transported across cell membranes primarily by LAT1 and 4F2hc, and imported into the mitochondria by the carrier SLC25A44 (mei2026branchedchainaminoacids pages 3-5, choi2024theroleof pages 1-2). Within the mitochondrial matrix, BCAT2 catalyzes the first transamination step, producing BCKAs and glutamate from BCAAs and 2-oxoglutarate (huang2025branchedchainaminoacids pages 4-5).

The BCKDH complex then catalyzes the irreversible, rate-limiting oxidative decarboxylation of BCKAs (mei2026branchedchainaminoacids pages 3-5). This commits the carbon skeletons to further catabolism through reactions specific to each amino acid, occurring exclusively in the mitochondrial matrix via pathways analogous to fatty acid oxidation (du2022theroleof pages 2-4). The end productsβ€”acetyl-CoA (from leucine and isoleucine) and succinyl-CoA (from valine and isoleucine)β€”enter the TCA cycle for complete oxidation and ATP production (mei2026branchedchainaminoacids pages 3-5, huang2025branchedchainaminoacids pages 4-5).

Physical interaction between BCAT2 and BCKDH has been demonstrated, and BCAT2 deficiency leads to abolished BCKDH activity, suggesting that substrate channeling or metabolon formation is functionally important (bo2024primaryrolesof pages 11-13).

Tissue-specific differences in BCAA metabolism are well established. BCAT2 is highly expressed in skeletal muscle but low in liver, while BCKDH activity is highest in the liver (bo2024primaryrolesof pages 9-11). Consequently, skeletal muscle is the major site of BCAA transamination, releasing BCKAs into the circulation, while the liver is the primary organ for BCKA oxidation, gluconeogenesis, and ketogenesis (bo2024primaryrolesof pages 9-11, bo2024primaryrolesof pages 11-13). BCAT and BCKDH enzyme activity is also high in skeletal muscle, adipose tissue, and brain (choi2024theroleof pages 2-3).

6. Regulation of BCKDH Complex Activity

The activity of the BCKDH complex is tightly regulated through reversible phosphorylation–dephosphorylation of the E1Ξ± subunit (BCKDHA), not the E1Ξ² subunit directly. BCKDK (branched-chain Ξ±-keto acid dehydrogenase kinase) phosphorylates E1Ξ± at serine residues 293 and 303, which inactivates the complex (huang2025branchedchainaminoacids pages 13-14, du2022theroleof pages 2-4). PPM1K (also known as PP2Cm), a mitochondrial PP2C-family phosphatase, dephosphorylates E1Ξ± to reactivate the complex (huang2025branchedchainaminoacids pages 13-14, huang2025branchedchainaminoacids pages 4-5).

This regulatory cycle is responsive to cellular metabolic status. BCKAs, particularly KIC (the leucine-derived ketoacid), allosterically inhibit BCKDK, thereby promoting BCKDH activation when BCAA concentrations are high (du2022theroleof pages 2-4). Conversely, BCKDK is upregulated under nutrient-excess conditions and suppressed during nutrient scarcity or catabolic stress (huang2025branchedchainaminoacids pages 13-14). The pharmacological BCKDK inhibitor BT2 binds BCKDK and causes its dissociation from the BCKDH complex, leading to dephosphorylation and activation of BCKDH, which increases BCAA oxidation and reduces serum BCAA levels (du2022theroleof pages 6-7).

Transcriptional regulation also modulates BCKDH complex activity. The transcription factor KLF15 upregulates expression of BCKDH subunit genes, including BCKDHB, in cardiac muscle, while PPARΞ³ regulates expression in adipose tissue (choi2024theroleof pages 2-3, ogawa2023downregulationofextramitochondrial pages 11-13).

A novel layer of regulation was recently described by Weiss et al. (2024), who identified a nuclear-encoded long non-coding RNA called mitolnc that localizes to mitochondria and directly interacts with the BCKDH complex to allosterically increase its activity, independent of phosphorylation. Inactivation of mitolnc in mice reduced BCKDH complex activity, causing BCAA accumulation in the heart and cardiac hypertrophy via enhanced mTOR signaling (weiss2024mitolnccontrolscardiac pages 10-12).

7. Disease Associations

7.1 Maple Syrup Urine Disease (MSUD)

Biallelic loss-of-function mutations in BCKDHB cause MSUD type 1B (OMIM #248611), an autosomal recessive inborn error of metabolism characterized by elevated BCAAs and BCKAs in blood and tissues, leading to neurotoxicity, encephalopathy, and, if untreated, death (campanholi2021molecularbasisof pages 1-2, rodriguezpombo2006mutationalspectrumof pages 1-3, billington2022genomicandbiochemical pages 1-3). The disease is named for the characteristic maple syrup odor of affected patients' urine. MSUD can also be caused by mutations in BCKDHA (type 1A), DBT (type II), or DLD.

Multiple population-based studies have identified a broad mutational spectrum in BCKDHB. In a Spanish cohort, 15 of 33 MSUD patients had E1Ξ² deficiency, with 14 different BCKDHB sequence variations identified, the most common being c.487G>T (p.Glu163X) found in 6 of 30 disease alleles (rodriguezpombo2006mutationalspectrumof pages 1-3). In a Malaysian cohort, 14 new mutations were identified across BCKDHA, BCKDHB, and DBT, including multiple missense mutations in BCKDHB (p.G101S, p.L194R, p.G66W, p.T365R, p.D88G, p.S261P, p.T273I) predicted to destabilize E1Ξ² protein structure (ali2018fourteennewmutations pages 7-8). In a Brazilian cohort, the Pro200Ter variant in BCKDHB was the most prevalent pathogenic mutation (19% of patients), and 9 of 12 classical phenotype patients had the E1Ξ² genetic subtype (margutti2020maplesyrupurine pages 2-4). An Egyptian study identified four BCKDHB variants including a biallelic duplication affecting exons 2–6 (OpenTargets Search: -BCKDHB). Chinese patient studies identified homozygous deletions (c.372_377del6 and c.713delC) causing frameshifts resulting in non-functional or truncated proteins (yang2012analysisofgene pages 6-6).

Structural analysis of MSUD mutations using the crystal structure explains their pathogenic mechanisms, including disruption of cofactor binding sites, potassium ion coordination, hydrophobic core packing, and subunit interfaces (Γ¦varsson2000crystalstructureof pages 1-2, Γ¦varsson2000crystalstructureof pages 7-8). Clinical phenotypes of MSUD include classic (most severe, neonatal onset), intermediate, intermittent, and thiamine-responsive forms, depending on residual enzyme activity (campanholi2021molecularbasisof pages 1-2).

OpenTargets database analysis confirms strong disease associations between BCKDHB and MSUD (association score 0.86), MSUD type 1B (0.79), hereditary disease (0.86), and skeletal abnormalities (0.45) (OpenTargets Search: -BCKDHB).

7.2 Broader Metabolic Disorders

Beyond MSUD, impaired BCKDH complex activity has been implicated in numerous metabolic disorders. Elevated plasma BCAAs are strongly associated with insulin resistance, type 2 diabetes, obesity, and cardiovascular disease (mei2026branchedchainaminoacids pages 3-5, huang2025branchedchainaminoacids pages 2-4). In genetically obese mice, rate-limiting BCKDH deficiency accompanies systemic suppression of BCAA catabolic genes, and restoring BCAA catabolic flux with BCKDK inhibitors markedly attenuates insulin resistance (du2022theroleof pages 6-7). In heart failure, impaired BCKDH activity leads to BCAA accumulation and cardiac dysfunction; pharmacological activation of BCKDH through BT2 decreases cardiac BCAA levels and improves heart function (ogawa2023downregulationofextramitochondrial pages 11-13). Furthermore, dysregulated BCAA metabolism has been implicated in cancer progression, where BCKDH activity may promote or suppress tumorigenesis in a context-dependent manner (he2026bcaasandrelated pages 8-10).

8. Summary

BCKDHB encodes the beta subunit of the E1 decarboxylase component of the mitochondrial BCKDH multienzyme complex, which catalyzes the irreversible oxidative decarboxylation of branched-chain alpha-ketoacidsβ€”the rate-limiting step in BCAA catabolism. The beta subunit is essential for ThDP cofactor binding at the α–β′ interface, potassium ion coordination, structural integrity of the Ξ±β‚‚Ξ²β‚‚ heterotetramer, and interaction with the E2 core of the complex. The BCKDH complex functions primarily in the mitochondrial matrix, where it commits BCAA-derived carbon skeletons to oxidative catabolism producing acetyl-CoA and succinyl-CoA for the TCA cycle. Complex activity is regulated by BCKDK-mediated phosphorylation (inactivation) and PPM1K-mediated dephosphorylation (activation) of the E1Ξ± subunit, as well as by allosteric mechanisms and, recently identified, lncRNA-mediated regulation. Loss-of-function mutations in BCKDHB cause MSUD type 1B, while broader impairment of BCKDH activity is implicated in insulin resistance, heart failure, and cancer metabolism.

References

  1. (Γ¦varsson2000crystalstructureof pages 1-2): Arnthor Γ†varsson, Jacinta L Chuang, R Max Wynn, Stewart Turley, David T Chuang, and Wim GJ Hol. Crystal structure of human branched-chain Ξ±-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure, 8:277-291, Mar 2000. URL: https://doi.org/10.1016/s0969-2126(00)00105-2, doi:10.1016/s0969-2126(00)00105-2. This article has 218 citations and is from a domain leading peer-reviewed journal.

  2. (billington2022genomicandbiochemical pages 1-3): Charles J. Billington, Kimberly A. Chapman, Eyby Leon, Beatrix W. Meltzer, Seth I. Berger, Matthew Olson, Robert A. Figler, Steve A. Hoang, Cui Wanxing, Brian R. Wamhoff, M. Sol Collado, and Kristina Cusmano‐Ozog. Genomic and biochemical analysis of repeatedly observed variants in dbt in individuals with maple syrup urine disease of central american ancestry. American Journal of Medical Genetics. Part a, 188:2738-2749, Jul 2022. URL: https://doi.org/10.1002/ajmg.a.62893, doi:10.1002/ajmg.a.62893. This article has 6 citations and is from a peer-reviewed journal.

  3. (Γ¦varsson2000crystalstructureof pages 7-8): Arnthor Γ†varsson, Jacinta L Chuang, R Max Wynn, Stewart Turley, David T Chuang, and Wim GJ Hol. Crystal structure of human branched-chain Ξ±-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure, 8:277-291, Mar 2000. URL: https://doi.org/10.1016/s0969-2126(00)00105-2, doi:10.1016/s0969-2126(00)00105-2. This article has 218 citations and is from a domain leading peer-reviewed journal.

  4. (Γ¦varsson2000crystalstructureof pages 2-4): Arnthor Γ†varsson, Jacinta L Chuang, R Max Wynn, Stewart Turley, David T Chuang, and Wim GJ Hol. Crystal structure of human branched-chain Ξ±-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure, 8:277-291, Mar 2000. URL: https://doi.org/10.1016/s0969-2126(00)00105-2, doi:10.1016/s0969-2126(00)00105-2. This article has 218 citations and is from a domain leading peer-reviewed journal.

  5. (Γ¦varsson2000crystalstructureof pages 4-5): Arnthor Γ†varsson, Jacinta L Chuang, R Max Wynn, Stewart Turley, David T Chuang, and Wim GJ Hol. Crystal structure of human branched-chain Ξ±-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure, 8:277-291, Mar 2000. URL: https://doi.org/10.1016/s0969-2126(00)00105-2, doi:10.1016/s0969-2126(00)00105-2. This article has 218 citations and is from a domain leading peer-reviewed journal.

  6. (du2022theroleof pages 1-2): Chuang Du, Wen-Jie Liu, Jing Yang, Shan-Shan Zhao, and Hui-Xin Liu. The role of branched-chain amino acids and branched-chain Ξ±-keto acid dehydrogenase kinase in metabolic disorders. Frontiers in Nutrition, Jul 2022. URL: https://doi.org/10.3389/fnut.2022.932670, doi:10.3389/fnut.2022.932670. This article has 98 citations.

  7. (du2022theroleof pages 2-4): Chuang Du, Wen-Jie Liu, Jing Yang, Shan-Shan Zhao, and Hui-Xin Liu. The role of branched-chain amino acids and branched-chain Ξ±-keto acid dehydrogenase kinase in metabolic disorders. Frontiers in Nutrition, Jul 2022. URL: https://doi.org/10.3389/fnut.2022.932670, doi:10.3389/fnut.2022.932670. This article has 98 citations.

  8. (ogawa2023downregulationofextramitochondrial pages 11-13): Toshifumi Ogawa, Hidemichi Kouzu, Arata Osanami, Yuki Tatekoshi, Tatsuya Sato, Atsushi Kuno, Yugo Fujita, Shoya Ino, Masaki Shimizu, Yuki Toda, Wataru Ohwada, Toshiyuki Yano, Masaya Tanno, Takayuki Miki, and Tetsuji Miura. Downregulation of extramitochondrial bckdh and its uncoupling from amp deaminase in type 2 diabetic oletf rat hearts. Physiological Reports, Feb 2023. URL: https://doi.org/10.14814/phy2.15608, doi:10.14814/phy2.15608. This article has 15 citations and is from a peer-reviewed journal.

  9. (ogawa2023downregulationofextramitochondrial pages 9-11): Toshifumi Ogawa, Hidemichi Kouzu, Arata Osanami, Yuki Tatekoshi, Tatsuya Sato, Atsushi Kuno, Yugo Fujita, Shoya Ino, Masaki Shimizu, Yuki Toda, Wataru Ohwada, Toshiyuki Yano, Masaya Tanno, Takayuki Miki, and Tetsuji Miura. Downregulation of extramitochondrial bckdh and its uncoupling from amp deaminase in type 2 diabetic oletf rat hearts. Physiological Reports, Feb 2023. URL: https://doi.org/10.14814/phy2.15608, doi:10.14814/phy2.15608. This article has 15 citations and is from a peer-reviewed journal.

  10. (weiss2024mitolnccontrolscardiac pages 10-12): Maria Weiss, Sara Hettrich, Theresa Hofmann, Salma Hachim, Stefan GΓΌnther, Thomas Braun, and Thomas Boettger. Mitolnc controls cardiac bcaa metabolism and heart hypertrophy by allosteric activation of bckdh. Nucleic Acids Research, 52:6629-6646, Apr 2024. URL: https://doi.org/10.1093/nar/gkae226, doi:10.1093/nar/gkae226. This article has 11 citations and is from a highest quality peer-reviewed journal.

  11. (Γ¦varsson2000crystalstructureof pages 10-12): Arnthor Γ†varsson, Jacinta L Chuang, R Max Wynn, Stewart Turley, David T Chuang, and Wim GJ Hol. Crystal structure of human branched-chain Ξ±-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure, 8:277-291, Mar 2000. URL: https://doi.org/10.1016/s0969-2126(00)00105-2, doi:10.1016/s0969-2126(00)00105-2. This article has 218 citations and is from a domain leading peer-reviewed journal.

  12. (margutti2020maplesyrupurine pages 2-4): Ana Vitoria Barban Margutti, Wilson AraΓΊjo Silva, Daniel Fantozzi Garcia, Greice Andreotti de Molfetta, Adriana Aparecida Marques, Tatiana Amorim, VΓ’nia Mesquita Gadelha Prazeres, Raquel Tavares Boy da Silva, Irene Kazue Miura, JoΓ£o Seda Neto, Emerson de Santana Santos, Mara LΓΊcia Schmitz Ferreira Santos, Charles Marques LourenΓ§o, TΓ‘ssia Tonon, Fernanda Sperb-Ludwig, Carolina Fischinger Moura de Souza, Ida Vanessa DΓΆederlein Schwartz, and JosΓ© Simon Camelo. Maple syrup urine disease in brazilian patients: variants and clinical phenotype heterogeneity. Orphanet Journal of Rare Diseases, Nov 2020. URL: https://doi.org/10.1186/s13023-020-01590-7, doi:10.1186/s13023-020-01590-7. This article has 18 citations and is from a peer-reviewed journal.

  13. (campanholi2021molecularbasisof pages 1-2): Diana Ruffato Resende Campanholi, Ana Vitoria Barban Margutti, Wilson A. Silva, Daniel F. Garcia, Greice A. Molfetta, Adriana A. Marques, Ida Vanessa DΓΆederlein Schwartz, V. Cornejo, Valerie Hamilton, Gabriela Castro, Fernanda Sperb‐Ludwig, Ester S. Borges, and JosΓ© S. Camelo. Molecular basis of various forms of maple syrup urine disease in chilean patients. Molecular Genetics & Genomic Medicine, May 2021. URL: https://doi.org/10.1002/mgg3.1616, doi:10.1002/mgg3.1616. This article has 10 citations and is from a peer-reviewed journal.

  14. (rodriguezpombo2006mutationalspectrumof pages 1-3): Pilar RodrΓ­guez-Pombo, Rosa Navarrete, BegoΓ±a Merinero, Paulino GΓ³mez-Puertas, and Magdalena Ugarte. Mutational spectrum of maple syrup urine disease in spain. Human Mutation, 27:715-715, Jul 2006. URL: https://doi.org/10.1002/humu.9428, doi:10.1002/humu.9428. This article has 69 citations and is from a domain leading peer-reviewed journal.

  15. (OpenTargets Search: -BCKDHB): Open Targets Query (-BCKDHB, 5 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

  16. (huang2025branchedchainaminoacids pages 13-14): Hui-Yu Huang, Shu-Ping Tsao, and Tu-Hsueh Yeh. Branched-chain amino acids in parkinson’s disease: molecular mechanisms and therapeutic potential. International Journal of Molecular Sciences, 26:6992, Jul 2025. URL: https://doi.org/10.3390/ijms26146992, doi:10.3390/ijms26146992. This article has 13 citations.

  17. (du2022theroleof pages 6-7): Chuang Du, Wen-Jie Liu, Jing Yang, Shan-Shan Zhao, and Hui-Xin Liu. The role of branched-chain amino acids and branched-chain Ξ±-keto acid dehydrogenase kinase in metabolic disorders. Frontiers in Nutrition, Jul 2022. URL: https://doi.org/10.3389/fnut.2022.932670, doi:10.3389/fnut.2022.932670. This article has 98 citations.

  18. (mei2026branchedchainaminoacids pages 3-5): Jie Mei, Fu-yuan Yang, and Quan Gong. Branched-chain amino acids and insulin resistance in type 2 diabetes: from metabolic dysregulation to therapeutic targets. Frontiers in Endocrinology, Feb 2026. URL: https://doi.org/10.3389/fendo.2025.1643231, doi:10.3389/fendo.2025.1643231. This article has 4 citations.

  19. (huang2025branchedchainaminoacids pages 4-5): Hui-Yu Huang, Shu-Ping Tsao, and Tu-Hsueh Yeh. Branched-chain amino acids in parkinson’s disease: molecular mechanisms and therapeutic potential. International Journal of Molecular Sciences, 26:6992, Jul 2025. URL: https://doi.org/10.3390/ijms26146992, doi:10.3390/ijms26146992. This article has 13 citations.

  20. (he2026bcaasandrelated pages 8-10): Binfan He, Lingxi Li, Ye Liu, Mengmeng Hao, Ling Zhang, and Rongzhang He. Bcaas and related metabolic enzymes: partners in crime driving tumor development. Frontiers in Cell and Developmental Biology, Feb 2026. URL: https://doi.org/10.3389/fcell.2026.1748587, doi:10.3389/fcell.2026.1748587. This article has 0 citations.

  21. (huang2025branchedchainaminoacids pages 2-4): Hui-Yu Huang, Shu-Ping Tsao, and Tu-Hsueh Yeh. Branched-chain amino acids in parkinson’s disease: molecular mechanisms and therapeutic potential. International Journal of Molecular Sciences, 26:6992, Jul 2025. URL: https://doi.org/10.3390/ijms26146992, doi:10.3390/ijms26146992. This article has 13 citations.

  22. (Γ¦varsson2000crystalstructureof pages 5-7): Arnthor Γ†varsson, Jacinta L Chuang, R Max Wynn, Stewart Turley, David T Chuang, and Wim GJ Hol. Crystal structure of human branched-chain Ξ±-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure, 8:277-291, Mar 2000. URL: https://doi.org/10.1016/s0969-2126(00)00105-2, doi:10.1016/s0969-2126(00)00105-2. This article has 218 citations and is from a domain leading peer-reviewed journal.

  23. (choi2024theroleof pages 1-2): Byeong Hun Choi, Seunghoon Hyun, and Seung-Hoi Koo. The role of bcaa metabolism in metabolic health and disease. Experimental & Molecular Medicine, 56:1552-1559, Jul 2024. URL: https://doi.org/10.1038/s12276-024-01263-6, doi:10.1038/s12276-024-01263-6. This article has 130 citations and is from a peer-reviewed journal.

  24. (bo2024primaryrolesof pages 11-13): Tomoki Bo and Junichi Fujii. Primary roles of branched chain amino acids (bcaas) and their metabolism in physiology and metabolic disorders. Molecules, 30:56, Dec 2024. URL: https://doi.org/10.3390/molecules30010056, doi:10.3390/molecules30010056. This article has 61 citations.

  25. (bo2024primaryrolesof pages 9-11): Tomoki Bo and Junichi Fujii. Primary roles of branched chain amino acids (bcaas) and their metabolism in physiology and metabolic disorders. Molecules, 30:56, Dec 2024. URL: https://doi.org/10.3390/molecules30010056, doi:10.3390/molecules30010056. This article has 61 citations.

  26. (choi2024theroleof pages 2-3): Byeong Hun Choi, Seunghoon Hyun, and Seung-Hoi Koo. The role of bcaa metabolism in metabolic health and disease. Experimental & Molecular Medicine, 56:1552-1559, Jul 2024. URL: https://doi.org/10.1038/s12276-024-01263-6, doi:10.1038/s12276-024-01263-6. This article has 130 citations and is from a peer-reviewed journal.

  27. (ali2018fourteennewmutations pages 7-8): Ernie Zuraida Ali and Lock-Hock Ngu. Fourteen new mutations of bckdha, bckdhb and dbt genes associated with maple syrup urine disease (msud) in malaysian population. Dec 2018. URL: https://doi.org/10.1016/j.ymgmr.2018.08.006, doi:10.1016/j.ymgmr.2018.08.006. This article has 43 citations.

  28. (yang2012analysisofgene pages 6-6): Nan Yang, Lianshu Han, Xuefan Gu, Jun Ye, Wenjuan Qiu, Huiwen Zhang, Zhuwen Gong, and Yafen Zhang. Analysis of gene mutations in chinese patients with maple syrup urine disease. Molecular genetics and metabolism, 106 4:412-8, Aug 2012. URL: https://doi.org/10.1016/j.ymgme.2012.05.023, doi:10.1016/j.ymgme.2012.05.023. This article has 45 citations and is from a peer-reviewed journal.

Artifacts

Citations

  1. weiss2024mitolnccontrolscardiac pages 10-12
  2. ogawa2023downregulationofextramitochondrial pages 9-11
  3. huang2025branchedchainaminoacids pages 4-5
  4. mei2026branchedchainaminoacids pages 3-5
  5. du2022theroleof pages 2-4
  6. bo2024primaryrolesof pages 11-13
  7. bo2024primaryrolesof pages 9-11
  8. choi2024theroleof pages 2-3
  9. huang2025branchedchainaminoacids pages 13-14
  10. du2022theroleof pages 6-7
  11. rodriguezpombo2006mutationalspectrumof pages 1-3
  12. ali2018fourteennewmutations pages 7-8
  13. margutti2020maplesyrupurine pages 2-4
  14. yang2012analysisofgene pages 6-6
  15. campanholi2021molecularbasisof pages 1-2
  16. ogawa2023downregulationofextramitochondrial pages 11-13
  17. he2026bcaasandrelated pages 8-10
  18. billington2022genomicandbiochemical pages 1-3
  19. du2022theroleof pages 1-2
  20. huang2025branchedchainaminoacids pages 2-4
  21. choi2024theroleof pages 1-2
  22. https://doi.org/10.1016/s0969-2126(00
  23. https://doi.org/10.1002/ajmg.a.62893,
  24. https://doi.org/10.3389/fnut.2022.932670,
  25. https://doi.org/10.14814/phy2.15608,
  26. https://doi.org/10.1093/nar/gkae226,
  27. https://doi.org/10.1186/s13023-020-01590-7,
  28. https://doi.org/10.1002/mgg3.1616,
  29. https://doi.org/10.1002/humu.9428,
  30. https://doi.org/10.3390/ijms26146992,
  31. https://doi.org/10.3389/fendo.2025.1643231,
  32. https://doi.org/10.3389/fcell.2026.1748587,
  33. https://doi.org/10.1038/s12276-024-01263-6,
  34. https://doi.org/10.3390/molecules30010056,
  35. https://doi.org/10.1016/j.ymgmr.2018.08.006,
  36. https://doi.org/10.1016/j.ymgme.2012.05.023,

πŸ“š Additional Documentation

Notes

(BCKDHB-notes.md)

BCKDHB (P21953) review notes

Identity

  • 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial (ODBB_HUMAN); BCKDE1B / BCKDH E1-beta.
  • EC 1.2.4.4. HGNC:987. NCBITaxon:9606.
  • Precursor: transit peptide 1..50 (mitochondrial); mature chain 51..392.
  • ComplexPortal CPX-2216 "Mitochondrial 2-oxoisovalerate dehydrogenase complex".

Core biology (from UniProt P21953, verified quotes)

  • FUNCTION: "Together with BCKDHA forms the heterotetrameric E1 subunit of the mitochondrial branched-chain
    alpha-ketoacid dehydrogenase (BCKD) complex. The BCKD complex catalyzes the multi-step oxidative
    decarboxylation of alpha-ketoacids derived from the branched-chain amino-acids valine, leucine and
    isoleucine producing CO2 and acyl-CoA..." "The E1 subunit catalyzes the first step with the
    decarboxylation of the alpha-ketoacid forming an enzyme-product intermediate. A reductive acylation
    mediated by the lipoylamide cofactor of E2 extracts the acyl group from the E1 active site..."
  • SUBUNIT: "Heterotetramer of 2 alpha/BCKDHA and 2 beta chains/BCKDHB that forms the branched-chain
    alpha-keto acid decarboxylase (E1) component of the BCKD complex." Complex organized around E2
    (24-meric DBT core) + 6-12 E1 + ~6 E3 (DLD dimer).
  • COFACTOR: thiamine diphosphate (ThDP/TPP). BINDING 152 = ThDP (shared with alpha). Multiple K+ structural
    binding sites (178,180,181,228,231,233).
  • SUBCELLULAR LOCATION: Mitochondrion matrix.
  • INTERACTION: P21953 - P12694 (BCKDHA), NbExp=15 (IntAct EBI-1029067/EBI-1029053). This is the direct
    E1 heterotetramer partner. All 5 IPI GO:0005515 rows have WITH/FROM UniProtKB:P12694 = BCKDHA.

Catalysis (UniProt CATALYTIC ACTIVITY, RHEA)

  • RHEA:13457 (EC 1.2.4.4): lipoyl-lysyl-[protein] + 3-methyl-2-oxobutanoate (= alpha-ketoisovalerate, KIV
    from valine) + H+ = S(8)-2-methylpropanoyldihydrolipoyl-lysyl-[protein] + CO2. Evidence PubMed:10745006, 9582350.
  • RHEA:84639: with 4-methyl-2-oxopentanoate (KIC from leucine).
  • RHEA:84643: with (S)-3-methyl-2-oxopentanoate (KMV from isoleucine).
  • So E1 handles all three BCKAs (KIV, KIC, KMV) -> the three separate leucine/isoleucine/valine
    catabolic BP terms are all legitimate for BCKDHB.

Key literature (all cached abstract-only unless noted)

  • PMID:10745006 (Aevarsson 2000, Structure): crystal structure of human E1b, "the 170 kDa
    alpha(2)beta(2) heterotetrameric E1b component"; K+ ion sites; MSUD mutations explained. Full_text: false.
  • PMID:9582350 (Wynn 1998, JBC): "The E1 decarboxylase component of the human branched-chain ketoacid
    dehydrogenase complex comprises two E1alpha (45.5 kDa) and two E1beta (37.5 kDa) subunits forming an
    alpha2 beta2 tetramer." Assembly of E1 in type IA MSUD. Full_text: false.
  • PMID:3593587 (Ono 1987): Purification/characterization of human liver BCKADH complex; "The BCKADH
    effectively oxidized all of KIV, KIC, and KMV". Full_text: false.
  • PMID:2022752 (Nobukuni 1991, JCI): Complete E1beta defect from 11-bp deletion in mito targeting leader
    peptide; "BCKDH activity in the proband ... approximately 6% of the normal control level"; "The absence
    of the E1 beta subunit results in instability of the E1 alpha subunit." IMP support for complex,
    process, mitochondrion. Full_text: abstract only.
  • PMID:12902323 (Wynn 2003): His146-beta' essential catalytic residue in reductive acylation. His-alpha/beta
    active-site mechanism. (IPI to BCKDHA.)
  • PMID:15166214 (Li 2004): ThDP binding / phosphorylation-loop cross-talk in E1b. (IPI to BCKDHA.)
  • PMID:15576032 (Wynn 2004): Regulation of BCKDC by phosphorylation of Ser292-alpha; disorder of
    phosphorylation loop shuts off reductive acylation. (IPI to BCKDHA.)
  • PMID:28514442 (Huttlin 2017 BioPlex/Nature) & PMID:33961781 (Huttlin 2021 Cell): large-scale
    interactome; IPI GO:0005515 with BCKDHA. Full text available.
  • PMID:34800366 (Morgenstern 2021 Cell Metab): high-confidence human mito proteome (HTP), mitochondrion.

Disease

  • MSUD 1B (MIM:620698), autosomal recessive; E1-beta subunit deficiency (Type IB). BCAA (Leu/Ile/Val) and
    their BCKAs accumulate -> encephalopathy, neurodegeneration. (dismech Maple_Syrup_Urine_Disease.yaml.)

Curation plan

  • Core MF: GO:0003863 branched-chain 2-oxo acid dehydrogenase activity (contributes_to; heterotetrameric
    E1 catalytic activity β€” BCKDHB contributes to shared active site with BCKDHA). Label per GOA/UniProt.
  • Core BP: GO:0009083 branched-chain amino acid catabolic process (directly_involved_in).
  • Core CC: GO:0005759 mitochondrial matrix; in_complex GO:0160157 BCKDH complex.
  • IEA/IBA process terms (Leu/Ile/Val catabolism, response to nutrient) accept as non-core/accept-broader.
  • 5x protein binding IPI (all vs BCKDHA): MARK_AS_OVER_ANNOTATED per policy (bare protein binding,
    real but uninformative; the informative capture is the E1 heterotetramer complex + MF).
  • protein-containing complex GO:0032991 IEA: MODIFY -> too general vs GO:0160157.
  • Reactome/HPA/HTP location terms: accept.

Deep research

  • falcon deep research file polled; see final report for whether it landed within the 8-min window.

πŸ“„ View Raw YAML

id: P21953
gene_symbol: BCKDHB
product_type: PROTEIN
status: INITIALIZED
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  BCKDHB encodes the beta subunit (E1-beta / BCKDE1B) of the E1 component of the
  mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKDH) complex. Together
  with the E1-alpha subunit (BCKDHA) it forms an alpha2-beta2 heterotetrameric,
  thiamine diphosphate (ThDP)-dependent decarboxylase (2-oxoisovalerate dehydrogenase,
  EC 1.2.4.4). This E1 decarboxylase catalyses the first, committed and rate-limiting
  step of branched-chain amino acid (BCAA) catabolism: the oxidative decarboxylation
  of the branched-chain 2-oxo (alpha-keto) acids derived from valine, leucine and
  isoleucine (2-oxoisovalerate/KIV, 4-methyl-2-oxopentanoate/KIC, and
  (S)-3-methyl-2-oxopentanoate/KMV), producing CO2 and a branched-chain acyl group
  that is reductively transferred to the lipoyl cofactor of the E2 transacylase. The
  active site lies at the alpha-beta' interface, and the beta subunit contributes
  residues for ThDP binding, structural K+ coordination, and heterotetramer/E2
  assembly. The full BCKDH multienzyme complex is organized around a 24-meric E2
  (DBT) cubic core, to which multiple E1 (BCKDHA/BCKDHB) tetramers and E3 (DLD)
  dimers associate; complex activity is regulated by reversible phosphorylation of
  E1-alpha (by BCKDK) and dephosphorylation (by PPM1K/PP2Cm). BCKDHB acts in the
  mitochondrial matrix. Biallelic loss-of-function variants in BCKDHB cause maple
  syrup urine disease type Ib (MSUD 1B), in which loss of the beta subunit also
  destabilizes the alpha subunit and abolishes complex activity.
alternative_products:
- name: '1'
  id: P21953-1
- name: '2'
  id: P21953-2
  sequence_note: VSP_056370, VSP_056371
existing_annotations:
- term:
    id: GO:0009083
    label: branched-chain amino acid catabolic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Phylogenetic (IBA) propagation of the core biological process. As the E1-beta
      subunit of the BCKDH complex, BCKDHB is directly required for the committed,
      rate-limiting oxidative decarboxylation step of BCAA (valine/leucine/isoleucine)
      catabolism.
    action: ACCEPT
    reason: >-
      Correct and central to the gene's function; well supported by direct experimental
      evidence in human and orthologs. This is a core biological process for BCKDHB.
    supported_by:
    - reference_id: UniProtKB:P21953
      supporting_text: >-
        Together with BCKDHA forms the heterotetrameric E1 subunit of the mitochondrial
        branched-chain alpha-ketoacid dehydrogenase (BCKD) complex. The BCKD complex
        catalyzes the multi-step oxidative decarboxylation of alpha-ketoacids derived
        from the branched-chain amino-acids valine, leucine and isoleucine producing
        CO2 and acyl-CoA
- term:
    id: GO:0160157
    label: branched-chain alpha-ketoacid dehydrogenase complex
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: part_of
  review:
    summary: >-
      Phylogenetic (IBA) assignment of the cellular component. BCKDHB is an integral,
      constitutive subunit of the BCKDH complex, forming (with BCKDHA) the E1
      alpha2-beta2 decarboxylase that associates with the E2 (DBT) core and E3 (DLD).
    action: ACCEPT
    reason: >-
      Correct core localization to the multienzyme complex; supported by structural,
      biochemical and disease genetics evidence (heterotetrameric E1 component).
    supported_by:
    - reference_id: UniProtKB:P21953
      supporting_text: >-
        Heterotetramer of 2 alpha/BCKDHA and 2 beta chains/BCKDHB that
        forms the branched-chain alpha-keto acid decarboxylase (E1) component
        of the BCKD complex
- term:
    id: GO:0007584
    label: response to nutrient
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Phylogenetic (IBA) annotation reflecting that BCAA catabolic flux through BCKDH
      is nutritionally regulated. This is a broad, downstream physiological process
      rather than the molecular role of the beta subunit.
    action: KEEP_AS_NON_CORE
    reason: >-
      Not wrong at the pathway level (BCKDH activity is modulated by nutrient status
      via BCKDK/PPM1K), but this is a peripheral, non-core physiological association
      for the E1-beta subunit, not its direct molecular function.
- term:
    id: GO:0003863
    label: branched-chain 2-oxo acid dehydrogenase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic (IEA) assignment of the E1 decarboxylase molecular function
      (EC 1.2.4.4), mapped via ortholog, RHEA reactions (RHEA:13457/84639/84643) and
      EC. This is the core catalytic activity of the BCKDH E1 component.
    action: ACCEPT
    reason: >-
      The mapping is correct and matches the UniProt catalytic activity and the
      experimental IDA/IMP annotations of the same term. The IEA uses 'enables' whereas
      the manual annotations use 'contributes_to'; contributes_to is technically more
      precise for a subunit of a shared active site, but the IEA is not wrong at this
      level and captures the correct enzymatic function.
    supported_by:
    - reference_id: UniProtKB:P21953
      supporting_text: >-
        Reaction=N(6)-[(R)-lipoyl]-L-lysyl-[protein] + 3-methyl-2-oxobutanoate
    - reference_id: file:human/BCKDHB/BCKDHB-deep-research-falcon.md
      supporting_text: thiamine diphosphate (ThDP)-dependent decarboxylase
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: located_in
  review:
    summary: >-
      Electronic (IEA) assignment of mitochondrial matrix localization via ortholog and
      UniProt subcellular location keyword. BCKDH is a soluble matrix multienzyme complex.
    action: ACCEPT
    reason: >-
      Correct and consistent with the UniProt subcellular location and with NAS/ISS/TAS
      annotations of the same term.
    supported_by:
    - reference_id: UniProtKB:P21953
      supporting_text: 'SUBCELLULAR LOCATION: Mitochondrion matrix'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:12902323
  qualifier: enables
  review:
    summary: >-
      IPI 'protein binding' annotation whose WITH/FROM is UniProtKB:P12694 (BCKDHA),
      i.e. the direct E1-alpha partner with which BCKDHB forms the alpha2-beta2
      heterotetramer. This paper dissects the catalytic mechanism (His-alpha/His-beta'
      in reductive acylation) of the assembled E1.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      The interaction is real (BCKDHB obligately binds BCKDHA), but the bare
      'protein binding' term is uninformative. The biologically meaningful capture of
      this interaction is already provided by the E1 heterotetramer / BCKDH complex
      annotations (GO:0160157) and the E1 decarboxylase molecular function (GO:0003863).
    supported_by:
    - reference_id: UniProtKB:P21953
      supporting_text: 'P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:15166214
  qualifier: enables
  review:
    summary: >-
      IPI 'protein binding' annotation, WITH/FROM UniProtKB:P12694 (BCKDHA). This study
      addresses ThDP-binding / phosphorylation-loop cross-talk in the assembled E1
      decarboxylase, again reflecting the BCKDHB-BCKDHA E1 heterotetramer.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Real interaction but uninformative bare 'protein binding'. The E1 heterotetramer
      is better captured by the BCKDH complex (GO:0160157) and E1 activity (GO:0003863)
      annotations.
    supported_by:
    - reference_id: UniProtKB:P21953
      supporting_text: 'P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:15576032
  qualifier: enables
  review:
    summary: >-
      IPI 'protein binding' annotation, WITH/FROM UniProtKB:P12694 (BCKDHA). This paper
      concerns regulation of the assembled BCKDH complex by phosphorylation of E1-alpha,
      again reflecting the E1 heterotetramer interaction.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Real interaction but uninformative bare 'protein binding'; the meaningful content
      is captured by the complex (GO:0160157) and MF (GO:0003863) annotations.
    supported_by:
    - reference_id: UniProtKB:P21953
      supporting_text: 'P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:28514442
  qualifier: enables
  review:
    summary: >-
      Large-scale interactome (BioPlex) IPI, WITH/FROM UniProtKB:P12694 (BCKDHA),
      recovering the BCKDHB-BCKDHA interaction that constitutes the E1 heterotetramer.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      High-throughput detection of the genuine E1-alpha/E1-beta interaction, but the
      generic 'protein binding' term is uninformative and the interaction is already
      captured by the BCKDH complex annotation (GO:0160157).
    supported_by:
    - reference_id: UniProtKB:P21953
      supporting_text: 'P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  qualifier: enables
  review:
    summary: >-
      Large-scale interactome (BioPlex 3.0) IPI, WITH/FROM UniProtKB:P12694 (BCKDHA),
      again capturing the BCKDHB-BCKDHA E1 heterotetramer interaction.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Genuine but uninformative bare 'protein binding'; the meaningful E1-alpha
      interaction is captured by the BCKDH complex (GO:0160157) and E1 MF (GO:0003863).
    supported_by:
    - reference_id: UniProtKB:P21953
      supporting_text: 'P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;'
- term:
    id: GO:0006550
    label: L-isoleucine catabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Electronic (Ensembl Compara ortholog) transfer of a more granular BCAA subprocess.
      The BCKDH E1 decarboxylates KMV (the isoleucine-derived 2-oxo acid), so this is a
      correct, more specific descendant of BCAA catabolism.
    action: ACCEPT
    reason: >-
      Biochemically correct - the E1 decarboxylase acts on the isoleucine-derived
      branched-chain 2-oxo acid (S)-3-methyl-2-oxopentanoate (KMV). More granular than,
      and consistent with, the core GO:0009083 annotation; retain as non-core detail.
    supported_by:
    - reference_id: UniProtKB:P21953
      supporting_text: >-
        Reaction=N(6)-[(R)-lipoyl]-L-lysyl-[protein] + (S)-3-methyl-2-
    - reference_id: PMID:3593587
      supporting_text: The BCKADH effectively oxidized all of KIV, KIC, and KMV
- term:
    id: GO:0006552
    label: L-leucine catabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Electronic (Ensembl Compara ortholog) transfer. The BCKDH E1 decarboxylates KIC
      (4-methyl-2-oxopentanoate), the leucine-derived 2-oxo acid, so this granular BCAA
      subprocess is correct.
    action: ACCEPT
    reason: >-
      Biochemically correct (E1 acts on the leucine-derived branched-chain 2-oxo acid,
      4-methyl-2-oxopentanoate/KIC). More specific than, and consistent with, the core
      GO:0009083 annotation; retain as non-core detail.
    supported_by:
    - reference_id: UniProtKB:P21953
      supporting_text: >-
        Reaction=N(6)-[(R)-lipoyl]-L-lysyl-[protein] + 4-methyl-2-oxopentanoate
    - reference_id: PMID:3593587
      supporting_text: The BCKADH effectively oxidized all of KIV, KIC, and KMV
- term:
    id: GO:0006574
    label: L-valine catabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Electronic (Ensembl Compara ortholog) transfer. The BCKDH E1 decarboxylates KIV
      (3-methyl-2-oxobutanoate), the valine-derived 2-oxo acid, so this granular BCAA
      subprocess is correct.
    action: ACCEPT
    reason: >-
      Biochemically correct (E1 acts on the valine-derived branched-chain 2-oxo acid,
      3-methyl-2-oxobutanoate/KIV; RHEA:13457 is the experimentally verified human
      reaction). More specific than, and consistent with, the core GO:0009083
      annotation; retain as non-core detail.
    supported_by:
    - reference_id: UniProtKB:P21953
      supporting_text: >-
        Reaction=N(6)-[(R)-lipoyl]-L-lysyl-[protein] + 3-methyl-2-oxobutanoate
    - reference_id: PMID:3593587
      supporting_text: The BCKADH effectively oxidized all of KIV, KIC, and KMV
- term:
    id: GO:0032991
    label: protein-containing complex
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: part_of
  review:
    summary: >-
      Electronic (Ensembl Compara ortholog) transfer of the generic 'protein-containing
      complex' term. BCKDHB is a subunit of the specific, well-defined BCKDH complex.
    action: MODIFY
    reason: >-
      Correct but far too general: BCKDHB is part of the specific branched-chain
      alpha-ketoacid dehydrogenase complex, which is already directly annotated
      (GO:0160157) with stronger evidence. Replace the generic term with the specific one.
    proposed_replacement_terms:
    - id: GO:0160157
      label: branched-chain alpha-ketoacid dehydrogenase complex
    supported_by:
    - reference_id: UniProtKB:P21953
      supporting_text: >-
        Heterotetramer of 2 alpha/BCKDHA and 2 beta chains/BCKDHB that
        forms the branched-chain alpha-keto acid decarboxylase (E1) component
        of the BCKD complex
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: NAS
  original_reference_id: PMID:3593587
  qualifier: located_in
  review:
    summary: >-
      Non-traceable author statement (ComplexPortal-assigned) of matrix localization,
      supported by purification of the intact human liver BCKDH complex, a soluble
      matrix multienzyme complex.
    action: ACCEPT
    reason: >-
      Consistent with all other matrix annotations and with UniProt subcellular location.
      Correct core localization.
    supported_by:
    - reference_id: PMID:3593587
      supporting_text: >-
        Purification and characterization of human liver branched-chain alpha-keto acid
        dehydrogenase complex.
- term:
    id: GO:0009083
    label: branched-chain amino acid catabolic process
  evidence_type: IDA
  original_reference_id: PMID:3593587
  qualifier: involved_in
  review:
    summary: >-
      Direct experimental (IDA) annotation of the core BCAA catabolic process. The
      purified human liver BCKDH complex oxidized all three branched-chain 2-oxo acids
      (KIV, KIC, KMV), demonstrating its role in BCAA (valine/leucine/isoleucine)
      catabolism.
    action: ACCEPT
    reason: >-
      Direct biochemical evidence for the complex's role in BCAA catabolism; this is a
      core process for BCKDHB.
    supported_by:
    - reference_id: PMID:3593587
      supporting_text: >-
        The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding apparent Km
        values in the range of 14-17 microM for those alpha-keto acids.
- term:
    id: GO:0160157
    label: branched-chain alpha-ketoacid dehydrogenase complex
  evidence_type: IPI
  original_reference_id: PMID:3593587
  qualifier: part_of
  review:
    summary: >-
      ComplexPortal (CPX-2216) IPI annotation of BCKDHB as a subunit of the BCKDH
      complex, based on co-purification of the intact human liver complex.
    action: ACCEPT
    reason: >-
      Correct core complex membership, supported by biochemical purification showing the
      subunit composition of the human liver BCKDH complex.
    supported_by:
    - reference_id: PMID:3593587
      supporting_text: >-
        the purified enzyme complex gave three major bands having
        molecular weights of 51,000, 46,000, and 36,000
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  qualifier: located_in
  review:
    summary: >-
      Human Protein Atlas immunofluorescence (IDA) localization of BCKDHB to
      mitochondria. Less granular than the matrix annotations but consistent.
    action: ACCEPT
    reason: >-
      Correct localization; mitochondrion is a valid parent of the more specific
      mitochondrial matrix localization also annotated. Directly supported by
      immunofluorescence.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: NAS
  original_reference_id: PMID:10745006
  qualifier: located_in
  review:
    summary: >-
      Author statement (NAS, UniProt) of mitochondrial matrix localization, associated
      with the crystal structure paper of the human E1b heterotetramer.
    action: ACCEPT
    reason: >-
      Consistent with the UniProt subcellular location and all other matrix annotations;
      correct core localization.
    supported_by:
    - reference_id: UniProtKB:P21953
      supporting_text: 'SUBCELLULAR LOCATION: Mitochondrion matrix'
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: is_active_in
  review:
    summary: >-
      Sequence-similarity (ISS) transfer from ortholog (UniProtKB:P21839, rat E1-beta)
      asserting BCKDHB is active in the mitochondrial matrix, where the BCKDH complex
      functions.
    action: ACCEPT
    reason: >-
      Correct: the E1 decarboxylase acts within the mitochondrial matrix as part of the
      BCKDH complex. The 'is_active_in' qualifier appropriately links localization to
      the site of catalytic function.
    supported_by:
    - reference_id: UniProtKB:P21953
      supporting_text: 'SUBCELLULAR LOCATION: Mitochondrion matrix'
- term:
    id: GO:0120552
    label: branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA
  evidence_type: IMP
  original_reference_id: PMID:10745006
  qualifier: involved_in
  review:
    summary: >-
      Mutant-phenotype (IMP) annotation to the specific process of branched-chain
      alpha-keto acid decarboxylation. The crystal structure of human E1b rationalizes
      how MSUD mutations in the beta subunit impair this decarboxylation step.
    action: ACCEPT
    reason: >-
      Accurate, appropriately specific description of the E1 decarboxylase step in which
      BCKDHB participates. Supported by structural/mutational analysis of MSUD variants.
    supported_by:
    - reference_id: PMID:10745006
      supporting_text: >-
        The known
        MSUD mutations affect the functioning of E1b by interfering with the cofactor
        and K(+) sites, the packing of hydrophobic cores, and the precise arrangement of
        residues at or near several subunit interfaces.
- term:
    id: GO:0120552
    label: branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA
  evidence_type: IDA
  original_reference_id: PMID:3593587
  qualifier: involved_in
  review:
    summary: >-
      Direct experimental (IDA) annotation to the branched-chain alpha-keto acid
      decarboxylation process, supported by the purified human liver BCKDH complex
      oxidizing all three branched-chain 2-oxo acids.
    action: ACCEPT
    reason: >-
      Correct, appropriately specific process describing the reaction the E1 component
      (including BCKDHB) initiates. Directly supported by biochemical characterization.
    supported_by:
    - reference_id: PMID:3593587
      supporting_text: >-
        The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding apparent Km
        values in the range of 14-17 microM for those alpha-keto acids.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9865121
  qualifier: located_in
  review:
    summary: >-
      Reactome (TAS) matrix localization annotation from a curated pathway reaction
      involving the BCKDH complex.
    action: ACCEPT
    reason: >-
      Consistent with the UniProt subcellular location and the other matrix annotations;
      correct core localization from a curated pathway source.
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: HTP
  original_reference_id: PMID:34800366
  qualifier: located_in
  review:
    summary: >-
      High-throughput (HTP) mitochondrial proteomics localization of BCKDHB to
      mitochondria (Morgenstern et al. high-confidence human mitochondrial proteome).
    action: ACCEPT
    reason: >-
      Consistent with all other localization evidence; a valid (if less specific) parent
      of the mitochondrial matrix localization. Correct.
    supported_by:
    - reference_id: PMID:34800366
      supporting_text: >-
        Quantitative high-confidence human mitochondrial proteome and its dynamics
        in cellular context.
- term:
    id: GO:0160157
    label: branched-chain alpha-ketoacid dehydrogenase complex
  evidence_type: IMP
  original_reference_id: PMID:2022752
  qualifier: part_of
  review:
    summary: >-
      Mutant-phenotype (IMP) evidence that BCKDHB is part of the BCKDH complex: an
      11-bp deletion abolishing the beta subunit destabilizes E1-alpha and reduces
      complex activity to ~6% of normal, demonstrating BCKDHB is a required structural
      subunit.
    action: ACCEPT
    reason: >-
      Strong genetic/biochemical evidence that BCKDHB is an integral subunit of the
      BCKDH complex whose absence disassembles/inactivates the enzyme. Core complex
      membership.
    supported_by:
    - reference_id: PMID:2022752
      supporting_text: The absence of the E1 beta subunit results in instability of the E1 alpha subunit.
- term:
    id: GO:0160157
    label: branched-chain alpha-ketoacid dehydrogenase complex
  evidence_type: IDA
  original_reference_id: PMID:9582350
  qualifier: part_of
  review:
    summary: >-
      Direct experimental (IDA) evidence that BCKDHB is a subunit of the E1 component:
      reconstitution/assembly studies show wild-type E1 exists as alpha2-beta2 tetramers
      of E1-alpha and E1-beta.
    action: ACCEPT
    reason: >-
      Directly demonstrates BCKDHB as part of the E1 decarboxylase of the BCKDH complex
      (alpha2-beta2 tetramer). Core complex membership.
    supported_by:
    - reference_id: PMID:9582350
      supporting_text: >-
        The E1 decarboxylase component of the human branched-chain ketoacid
        dehydrogenase complex comprises two E1alpha (45.5 kDa) and two E1beta (37.5 kDa)
        subunits forming an alpha2 beta2 tetramer.
- term:
    id: GO:0160157
    label: branched-chain alpha-ketoacid dehydrogenase complex
  evidence_type: IDA
  original_reference_id: PMID:10745006
  qualifier: part_of
  review:
    summary: >-
      Direct experimental (IDA) evidence from the crystal structure of the human E1b
      component (170 kDa alpha2-beta2 heterotetramer), establishing BCKDHB as an
      integral subunit of the BCKDH complex.
    action: ACCEPT
    reason: >-
      Structural determination of the E1b heterotetramer directly demonstrates BCKDHB as
      part of the complex. Core complex membership.
    supported_by:
    - reference_id: PMID:10745006
      supporting_text: >-
        the 170 kDa
        alpha(2)beta(2) heterotetrameric E1b component of the
        branched-chain alpha-ketoacid dehydrogenase multienzyme complex.
- term:
    id: GO:0003863
    label: branched-chain 2-oxo acid dehydrogenase activity
  evidence_type: IDA
  original_reference_id: PMID:10745006
  qualifier: contributes_to
  review:
    summary: >-
      Direct experimental (IDA) annotation with the appropriate 'contributes_to'
      qualifier: BCKDHB contributes to the E1 decarboxylase molecular function. The
      crystal structure shows the active site at the alpha-beta' interface, with beta
      subunit residues involved in cofactor and K+ binding.
    action: ACCEPT
    reason: >-
      Core molecular function. 'contributes_to' correctly reflects that catalysis
      requires both subunits (active site at alpha-beta' interface); BCKDHB alone does
      not carry the full activity but is essential to it.
    supported_by:
    - reference_id: PMID:10745006
      supporting_text: >-
        The position of two important potassium (K(+)) ions was
        determined.
    - reference_id: UniProtKB:P21953
      supporting_text: >-
        The E1 subunit
        catalyzes the first step with the decarboxylation of the alpha-ketoacid
- term:
    id: GO:0003863
    label: branched-chain 2-oxo acid dehydrogenase activity
  evidence_type: IDA
  original_reference_id: PMID:9582350
  qualifier: contributes_to
  review:
    summary: >-
      Direct experimental (IDA) annotation of the E1 decarboxylase activity with
      'contributes_to'. E1-alpha missense mutations abolish E1 and BCKDH catalytic
      activity, and BCKDHB is a required subunit of the catalytically competent
      alpha2-beta2 E1.
    action: ACCEPT
    reason: >-
      Core molecular function; 'contributes_to' is correct for a shared active site
      formed by the alpha2-beta2 heterotetramer.
    supported_by:
    - reference_id: PMID:9582350
      supporting_text: >-
        the E1alpha subunit is
        affected, resulting in the loss of E1 and
        branched-chain ketoacid dehydrogenase catalytic activities.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5693148
  qualifier: located_in
  review:
    summary: >-
      Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction
      involving the BCKDH complex.
    action: ACCEPT
    reason: >-
      Consistent with all other matrix localization evidence; correct core localization.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5693153
  qualifier: located_in
  review:
    summary: >-
      Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction
      involving the BCKDH complex.
    action: ACCEPT
    reason: >-
      Consistent with all other matrix localization evidence; correct core localization.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9912527
  qualifier: located_in
  review:
    summary: >-
      Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction
      (BCKDH dephosphorylation by PPM1K) involving the BCKDH complex.
    action: ACCEPT
    reason: >-
      Consistent with all other matrix localization evidence; correct core localization.
- term:
    id: GO:0003863
    label: branched-chain 2-oxo acid dehydrogenase activity
  evidence_type: IMP
  original_reference_id: PMID:2022752
  qualifier: contributes_to
  review:
    summary: >-
      Mutant-phenotype (IMP) evidence for the E1 decarboxylase activity: loss of the
      beta subunit reduces BCKDH activity to ~6% of normal, demonstrating BCKDHB is
      required for the complex's dehydrogenase activity. Annotated with 'contributes_to'.
    action: ACCEPT
    reason: >-
      Core molecular function supported by loss-of-function genetics; 'contributes_to'
      is appropriate for a subunit of the shared active site.
    supported_by:
    - reference_id: PMID:2022752
      supporting_text: The BCKDH activity in the proband with MSUD was approximately 6% of the normal control level.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9859148
  qualifier: located_in
  review:
    summary: >-
      Reactome (TAS) mitochondrial matrix localization from the curated reaction in
      which the BCKDHA:BCKDHB E1 tetramer decarboxylates KIC, KMV and KIV.
    action: ACCEPT
    reason: >-
      Consistent with all other matrix localization evidence and directly describes the
      E1 catalytic reaction. Correct core localization.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9859163
  qualifier: located_in
  review:
    summary: >-
      Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction
      involving the BCKDH complex.
    action: ACCEPT
    reason: >-
      Consistent with all other matrix localization evidence; correct core localization.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9859172
  qualifier: located_in
  review:
    summary: >-
      Reactome (TAS) mitochondrial matrix localization from the curated reaction in
      which the DLD (E3) dimer dehydrogenates dihydrolipoyl, part of the BCKDH complex
      cycle.
    action: ACCEPT
    reason: >-
      Consistent with all other matrix localization evidence; correct core localization.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9865115
  qualifier: located_in
  review:
    summary: >-
      Reactome (TAS) mitochondrial matrix localization from a curated reaction involving
      DBT (E2) loss-of-function within the BCKDH pathway.
    action: ACCEPT
    reason: >-
      Consistent with all other matrix localization evidence; correct core localization.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9907572
  qualifier: located_in
  review:
    summary: >-
      Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction
      involving the BCKDH complex.
    action: ACCEPT
    reason: >-
      Consistent with all other matrix localization evidence; correct core localization.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9912480
  qualifier: located_in
  review:
    summary: >-
      Reactome (TAS) mitochondrial matrix localization from the curated reaction in
      which BCKDK loss-of-function mutations fail to phosphorylate BCKDH.
    action: ACCEPT
    reason: >-
      Consistent with all other matrix localization evidence; correct core localization.
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IMP
  original_reference_id: PMID:2022752
  qualifier: located_in
  review:
    summary: >-
      Mutant-phenotype (IMP) mitochondrial localization inference. The disease allele
      deletes part of the E1-beta mitochondrial targeting leader peptide, consistent
      with normal mitochondrial localization of the wild-type protein.
    action: ACCEPT
    reason: >-
      Correct localization; a valid parent of the mitochondrial matrix annotations.
      The mutation disrupts the mitochondrial targeting peptide, underscoring the
      protein's mitochondrial destination.
    supported_by:
    - reference_id: PMID:2022752
      supporting_text: >-
        An 11-bp deletion was identified in the region that encoded the
        mitochondrial targeting leader peptide in the E1 beta cDNA.
- term:
    id: GO:0009083
    label: branched-chain amino acid catabolic process
  evidence_type: IMP
  original_reference_id: PMID:2022752
  qualifier: involved_in
  review:
    summary: >-
      Mutant-phenotype (IMP) evidence for the core BCAA catabolic process: complete loss
      of the beta subunit causes MSUD (BCAA/BCKA accumulation) and reduces BCKDH activity
      to ~6% of normal, demonstrating BCKDHB's requirement for BCAA catabolism.
    action: ACCEPT
    reason: >-
      Strong loss-of-function evidence for a core biological process; MSUD 1B is the
      pathological consequence of impaired BCAA catabolism due to E1-beta deficiency.
    supported_by:
    - reference_id: PMID:2022752
      supporting_text: >-
        These observations show the biological importance of the E1 beta
        subunit of BCKDH to maintain normal function of the enzyme activity.
core_functions:
- description: >-
    E1-beta subunit of the BCKDH E1 decarboxylase; contributes (with BCKDHA) to the
    thiamine diphosphate-dependent oxidative decarboxylation of branched-chain 2-oxo
    (alpha-keto) acids, the committed and rate-limiting step of branched-chain amino
    acid catabolism.
  molecular_function:
    id: GO:0003863
    label: branched-chain 2-oxo acid dehydrogenase activity
  directly_involved_in:
  - id: GO:0009083
    label: branched-chain amino acid catabolic process
  locations:
  - id: GO:0005759
    label: mitochondrial matrix
  in_complex:
    id: GO:0160157
    label: branched-chain alpha-ketoacid dehydrogenase complex
  supported_by:
  - reference_id: UniProtKB:P21953
    supporting_text: >-
      Together with BCKDHA forms the heterotetrameric E1 subunit of
      the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD)
      complex.
  - reference_id: PMID:10745006
    supporting_text: >-
      the 170 kDa
      alpha(2)beta(2) heterotetrameric E1b component of the
      branched-chain alpha-ketoacid dehydrogenase multienzyme complex.
references:
- id: file:human/BCKDHB/BCKDHB-deep-research-falcon.md
  title: BCKDHB (P21953) deep research report (falcon / Edison Scientific Literature)
  findings: []
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
    by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:10745006
  title: Crystal structure of human branched-chain alpha-ketoacid dehydrogenase and
    the molecular basis of multienzyme complex deficiency in maple syrup urine disease.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified. Crystal structure of the human E1b alpha2-beta2 heterotetramer;
      directly establishes BCKDHB as a subunit of the E1 decarboxylase and its role in
      cofactor/K+ binding. Cached abstract only (full_text_available: false), but the
      catalytic-activity and structural claims are also anchored in UniProt.
- id: PMID:12902323
  title: 'Roles of His291-alpha and His146-beta'' in the reductive acylation reaction
    catalyzed by human branched-chain alpha-ketoacid dehydrogenase: refined phosphorylation
    loop structure in the active site.'
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Mechanistic study of the assembled E1; basis for an IPI 'protein binding'
      annotation (WITH/FROM BCKDHA). Cached abstract only.
- id: PMID:15166214
  title: Cross-talk between thiamin diphosphate binding and phosphorylation loop conformation
    in human branched-chain alpha-keto acid decarboxylase/dehydrogenase.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Basis for an IPI 'protein binding' annotation (WITH/FROM BCKDHA), reflecting the
      E1 heterotetramer. Cached abstract only.
- id: PMID:15576032
  title: Molecular mechanism for regulation of the human mitochondrial branched-chain
    alpha-ketoacid dehydrogenase complex by phosphorylation.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Regulation of the assembled complex by E1-alpha phosphorylation; basis for an
      IPI 'protein binding' annotation (WITH/FROM BCKDHA). Cached abstract only.
- id: PMID:2022752
  title: Maple syrup urine disease. Complete defect of the E1 beta subunit of the
    branched chain alpha-ketoacid dehydrogenase complex due to a deletion of an 11-bp
    repeat sequence which encodes a mitochondrial targeting leader peptide in a family
    with the disease.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified. Directly on BCKDHB (E1-beta): 11-bp deletion in the
      mitochondrial targeting peptide; loss of E1-beta destabilizes E1-alpha and reduces
      BCKDH activity to ~6% of normal. Supports complex membership, BCAA catabolism, and
      mitochondrial localization annotations. Full text (JCI, PMC295312) available.
- id: PMID:28514442
  title: Architecture of the human interactome defines protein communities and disease
    networks.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Large-scale BioPlex interactome; basis for a high-throughput IPI 'protein binding'
      annotation with BCKDHA (E1 heterotetramer). Recovers the genuine interaction but
      uninformative at the bare protein-binding level.
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human
    interactome.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Large-scale BioPlex 3.0 interactome; basis for a high-throughput IPI 'protein
      binding' annotation with BCKDHA. Genuine but uninformative bare protein binding.
- id: PMID:34800366
  title: Quantitative high-confidence human mitochondrial proteome and its dynamics
    in cellular context.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      High-confidence human mitochondrial proteome (HTP); supports mitochondrial
      localization of BCKDHB.
- id: PMID:3593587
  title: Purification and characterization of human liver branched-chain alpha-keto
    acid dehydrogenase complex.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified. Purification of the intact human liver BCKDH complex; shows the
      complex oxidizes all three branched-chain 2-oxo acids (KIV, KIC, KMV). Supports the
      MF, BCAA catabolism, decarboxylation and complex-membership annotations. Cached
      abstract only.
- id: PMID:9582350
  title: Impaired assembly of E1 decarboxylase of the branched-chain alpha-ketoacid
    dehydrogenase complex in type IA maple syrup urine disease.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified. Establishes the E1 decarboxylase as an alpha2-beta2 tetramer of
      E1-alpha and E1-beta; supports BCKDHB complex membership and its contribution to
      E1 catalytic activity. Cached abstract only.
- id: Reactome:R-HSA-5693148
  title: "BCKDK phosphorylates BCKDH"
  findings: []
- id: Reactome:R-HSA-5693153
  title: "PPM1K dephosphorylates p-BCKDH"
  findings: []
- id: Reactome:R-HSA-9859148
  title: "BCKDHA:BCKDHB tetramer decarboxylates KIC, KMVA, KIV"
  findings: []
- id: Reactome:R-HSA-9859163
  title: "DBT transfers BCAA to CoA"
  findings: []
- id: Reactome:R-HSA-9859172
  title: "DLD dimer dehydrogenates dihydrolipoyl"
  findings: []
- id: Reactome:R-HSA-9865115
  title: "DBT loss-of-function mutants don't synthesize BCAA-CoA"
  findings: []
- id: Reactome:R-HSA-9865121
  title: "BCKDHA or BCKDHB loss-of-function mutants don't synthesize BCAA-CoA"
  findings: []
- id: Reactome:R-HSA-9907572
  title: "Loss-of-function DLD mutants don't dehydrogenate dihydrolipoyl DBT"
  findings: []
- id: Reactome:R-HSA-9912480
  title: "BCKDK loss-of-function mutations do not phosphorylate BCKDH"
  findings: []
- id: Reactome:R-HSA-9912527
  title: "H139Hfs13* PPM1K does not dephosphorylate BCKDH"
  findings: []